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SUMMARY 
Smartphone-based telehealth is steadily transforming the delivery of medical care 
worldwide, moving diagnosis of disease from the clinic to the home to potentially 
anywhere in the globe.  Smartphone images alone have recently been used by physicians 
to remotely diagnose a myriad of diseases. However, smartphone telehealth approaches 
have yet to non-invasively replace blood-based testing, which remains a major 
cornerstone of disease diagnosis in modern medicine. While the addition of specialized 
smartphone attachments and supplemental calibration tools may enable point-of-care 
diagnosis and analysis of tissue and bodily fluid samples, the additional burden of blood 
and/or tissue sample collections combined with the additional cost and inconvenience 
associated with this equipment, prevents worldwide use of these potentially disruptive 
approaches. Therefore, a smartphone-based system, requiring nothing other than the 
smartphones native technology and capable of non-invasively replacing blood-based 
diagnostics, would transform the very nature of telehealth and the delivery of healthcare 
worldwide. Towards that end, I specifically focused on anemia, a potentially life-
threatening disorder characterized by low blood hemoglobin (Hgb) levels that affects 
approximately 2 billion people worldwide. Despite the high prevalence of anemia, all 
existing diagnostic approaches to measure Hgb require specialized equipment and 
represent tradeoffs between invasiveness, accuracy, infrastructure needs, and expense. 
Aside from being cost-prohibitive, the necessary invasive blood sampling to measure 
Hgb levels causes discomfort and trauma in younger pediatric patients. By examining 
clinical pallor, a common symptom of anemia, I developed a methodology that 
 xiii 
quantitatively analyzes patient-sourced photos using smartphone-based algorithms to 
enable a noninvasive, accurate, and accessible anemia diagnostic. Here, a patient simply 
takes a picture of their fingernail beds using their smartphone, and the image analysis 
algorithm analyzes color data and image metadata to measure the corresponding Hgb 
level. By quantifying clinical pallor, this system non-invasively measures Hgb levels to 
within a clinically significant and well accepted margin of error (±2.6 g/dL) of the gold 
standard Hgb measurement tool with a sensitivity and specificity of 0.90 and 0.82, 
respectively, of predicting anemia (defined as Hgb < 11.0g/dL) in 100 pediatric patients 
at Children’s Healthcare of Atlanta with anemia of any etiology mixed with healthy 
subjects. Furthermore, this algorithm can be personally calibrated to achieve and 
accuracy of ±0.9 g/dL, a degree of accuracy which, upon further testing, may enable this 
technique to replace traditional blood-based testing. This algorithm has been 
implemented into a smartphone app that is capable of outperforming trained 
hematologists in physical examination-based Hgb measurement. Overall, this technology 
has the capability to change the treatment paradigm for anemia as patients no longer need 
to visit a clinic to monitor their hemoglobin. In this thesis, I discuss the development of 




CHAPTER 1. INTRODUCTION 
1.1 Motivation 
Anemia, characterized by low blood  hemoglobin (Hgb) levels1, is a global public 
health problem that affects an estimated 1 in 3 people worldwide. Anemia is caused by a 
variety of etiologies, including chronic hematological conditions that disproportionately 
affect underserved populations, such as sickle cell disease and β-thalassemia2,3. Patients 
suffering from chronic anemia require frequent monitoring of their Hgb levels to track 
the progression of their disease and inform their treatment strategy. The gold standard 
Hgb measurement test is the complete blood count (CBC) which typically requires a 
blood draw and trained laboratory technicians as well as expensive analytical equipment 
and reagents4. Despite the high prevalence of anemia, there is currently no noninvasive, 
inexpensive, and accurate Hgb assessment technology available that enables patients with 
chronic conditions to better self-manage their disease5-7. 
To that end, advancements in point-of-care (POC) technology are dramatically 
and cost-effectively improving clinical outcomes and quality of life of patients with 
chronic diseases by facilitating patient-provider communication and enabling self-
management8. Smartphones offer an ideal POC platform, as they are already distributed 
worldwide and in the hands of billions of users9. Recently, patients have used 
smartphones to capture and transmit images to physicians for remote diagnosis, such as in 
cases of ear infections or melanoma10,11. Moreover, with customized attachments, 
smartphones have been widely adapted to perform POC diagnostic analysis on body 
tissue and fluid samples12. However, there are currently no smartphone-based approaches 
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that can non-invasively replace blood-based diagnostics (e.g. Hgb measurement), a major 
cornerstone in the practice of modern medicine. A patient-operated, home-based method 
to measure Hgb as a self-test would dramatically improve the quality of life of chronic 
anemia patients, as this would obviate the need for frequent, time-consuming, and 
expensive clinic visits to measure Hgb levels.   
To address these challenges, I have developed and clinically validated a novel, 
non-invasive smartphone-based technology capable of accurately measuring blood Hgb 
levels using only patient-sourced images and the phone’s native hardware without 
additional attachments or calibration tools. Using this smartphone app, a patient simply 
takes an image of their fingernail beds, where a custom, novel, image analysis algorithm 
calculates that patient’s Hgb level based on the pallor of their fingernail beds (Figure 1). 
Clinicians have used physical examination of the fingernails, conjunctiva, and palmar 
creases for qualitative assessment of anemia, and several groups have semi-quantitatively 
characterized anemia using these clinical findings13-17. Combining this clinically 
Figure 1: This smartphone app enables non-invasive, quantitative self-
measurement of patient blood Hgb levels. A) A patient takes a photo of their 
fingernail beds. B) Using the native hardware on the smartphone, without needing any 
attachments or calibration equipment, (C) the image analysis algorithm quantitatively 
measures Hgb levels. 
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established utility of physical examination in anemia diagnosis with the imaging 
capabilities of smartphones, this image analysis algorithm relates clinical pallor of the 
fingernail beds from patient images to quantitative Hgb levels.  
1.2 Research Objectives and Specific Aims 
The overall goals of this project were to: (Aim1) determine the feasibility of 
developing an image analysis algorithm that can accurately predict Hgb values from 
smartphone images of subject’s fingernails, (Aim 2) develop the anemia prediction 
algorithm and validate with a large scale clinical assessment (n = 337), and (Aim 3) 
perform usability testing and incorporate this algorithm into a translational, easy to use, 
and inexpensive smartphone application. The incorporation of this image analysis 
algorithm into a mobile platform in the form of an app ultimately facilitates patient self-
management by allowing chronic anemia patients to measure their own Hgb levels, 
enabling more effective patient-provider communication, as well as improving access to 
healthcare especially in low resource settings. 
1.2.1 Aim 1: Determine the feasibility of developing an image analysis algorithm that 
can accurately predict Hgb values from smartphone images of subjects 
fingernails 
In this aim, I showed that it is possible to quantitatively correlate the clinical pallor in a 
patients fingernail beds to the patient’s blood Hgb concentration.  Images of fingernail beds were 
taken using a smartphone and multiple parameters were extracted from the images. These 
parameters were then correlated with actual Hgb levels to determine their relationships to blood 
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Hgb level. Accurate Hgb levels used to evaluate the regression analysis were obtained via a blood 
draw and subsequent measurement via a CBC, the gold standard for measuring anemia. 
1.2.2 Aim 2: Validate and improve the anemia monitoring algorithm with a large scale 
clinical assessment 
In this aim, I conducted a large scale validation study at Children’s Healthcare of Atlanta 
(CHOA), to evaluate the accuracy of the Hgb measurement algorithm. Multi-linear regression 
was used to correlate image parameters of subject’s fingernail beds with gold-standard measured 
Hgb. Once an algorithm that accurately predicts Hgb values was developed, the algorithm was 
validated in a large scale clinical assessment. This involved taking images of hospitalized 
patient’s fingernail beds, and comparing the Hgb results of the prediction algorithm with results 
from the gold standard obtained during the course of the patient’s standard treatment protocol.  
Additionally, chronically anemic patients whose Hgb levels fluctuate were monitored over time 
to assess the utility of this prediction algorithm as a self-monitoring tool that can be tailored to an 
individual’s physical characteristics. Data collected from this clinical study was then used to 
iteratively improve the prediction algorithm 
1.2.3 Perform usability testing and incorporate this algorithm into a translational, easy 
to use, and inexpensive smartphone application 
In this aim, I incorporated the Hgb measurement algorithm in smartphone apps running 
on both the iOS and Android operating systems. Testing was conducted to determine the testing 
conditions under which the app will work. This was done by comparing the accuracy of the app 
when testing was conducted using multiple different smartphones as well as varying background 




Anemia, characterized by low blood Hgb levels, is the world’s most common 
blood disorder, afflicting nearly two billion people worldwide1. Due to numerous causes 
including malnutrition (e.g. iron deficiency), genetic diseases (e.g. sickle cell disease and 
β-thalassemia), infections/inflammatory disorders, cancer chemotherapy, and renal 
failure, anemia can be chronic and potentially life-threatening2,18-22. Therefore, at-risk 
individuals, especially those with chronic anemia, require frequent Hgb level 
measurements to monitor their disease and dictate their treatment plan. For example, 
sickle cell disease, β-thalassemia, and marrow failure often require chronic transfusions, 
the amount and timing of which are determined by Hgb levels. Also, patients with 
autoimmune anemia require frequent Hgb measurements to determine their medication 
type and dosage. Currently, the gold-standard Hgb diagnostic is the CBC4, which requires 
a costly patient visit to a clinic/hospital or commercial lab, expensive analytical 
equipment, as well as trained phlebotomists/technicians. Often the transportation logistics 
alone to obtain these labs are cost-prohibitive to patients, especially those who are 
members of underserved populations, and the necessary invasive blood sampling to 
measure Hgb levels causes discomfort and trauma in younger pediatric patients, a known 
demographic at risk for anemia23. Due to the inconvenience, invasiveness, lack of 
accessibility, and cost associated with CBCs, POC Hgb diagnostics have been developed 
to address some of these issues, but current systems all suffer from some combination of 
high-cost (handheld Hgb meters cost USD $30-$1000), inaccuracy, the need for blood 
sampling, and incompatibility with patient self-testing at home5,7,24,25. Therefore, a 
noninvasive, inexpensive, easily accessible (i.e. using only the native hardware of the 
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phone without the need for additional equipment) anemia diagnostic that accurately 
measures a patient’s Hgb levels, especially as a patient self-test, can vastly improve the 
quality of life of chronic anemia patients. Furthermore, chronic anemia conditions such as 
sickle cell disease and β-thalassemia primarily affect underserved populations, further 
necessitating the need for such an inexpensive technology.  
Towards that end, smartphone-based mobile health (mHealth) is steadily 
transforming the delivery of medical care worldwide, moving diagnosis of disease from 
the clinic to the home to potentially anywhere in the globe and facilitating enhanced 
patient-provider communication26. As examples, smartphone images of the skin, ears, and 
eyes have recently been used by physicians to remotely diagnose melanoma, ear 
infections, and corneal abrasions, respectively10,11,27. However, smartphone mHealth 
approaches have yet to non-invasively replace blood-based testing, which remains a 
major cornerstone of disease diagnosis in modern medicine. While the addition of 
specialized smartphone attachments and supplemental calibration tools may enable POC 
diagnosis and analysis of tissue and bodily fluid samples12, the additional burden of blood 
and/or tissue sample collections combined with the additional cost and inconvenience 
associated with acquisition of the additional equipment prevents worldwide use of these 
potentially disruptive approaches. Therefore, the smartphone-based, patient-operated Hgb 
measurement system that I have developed, which requires nothing other than the native 
technology of the smartphone itself and is potentially capable of non-invasively replacing 
blood-based diagnostics, would transform the very nature of mHealth and delivery of 
healthcare worldwide. To that end, this technology will fundamentally shift the treatment 
paradigm and improve the quality of life of chronic anemia patients. 
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More broadly, by moving Hgb measurement from the clinic to the bedside, any 
patient in any location, at any time, now has access to an important health metric and may 
seek care accordingly. This technology has the potential to significantly impact 
individuals with chronic anemia, which disproportionately impacts underserved 
populations. For example, each year in the United States, approximately 2.25 million 
units of blood are transfused to 750,000 hematology/oncology patients, the majority of 
whom suffer from chronic anemia28. A Hgb measurement is taken prior to administration 
(typically using a CBC) of each blood transfusion to determine eligibility for a 
transfusion. Using this technology, these patients could monitor their anemia from the 
comfort of their own home, sending results directly to a physician to remotely assess their 
need for a transfusion, rather than through inconvenient, recurring, and costly clinic 
visits. In addition, patients with sickle cell disease, milder forms of thalassemia, and 
cancer patients undergoing chemotherapy, all of whom are already chronically anemic, 
may experience dangerous and precipitous drops in their Hgb levels from issues as 
benign as an upper respiratory viral infection and therefore require frequent Hgb 
monitoring2. The ability to self-test at home may save the patient from unnecessary clinic 
visits, as well as more quickly detect severe Hgb level drops. Moreover, this technology 
has far reaching global health applications as healthcare officials in low resource settings 
may use this technology to inform allocation of limited healthcare resources (e.g. 
transfusions, high-risk obstetrical services, etc.) for the patients with the most severe 
anemia. Furthermore, while this algorithm is currently focused on anemia, this approach 
can potentially be easily adapted to quantify other conditions that manifest in physical 
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exam findings and currently require blood tests (i.e. jaundice and cyanosis), 
demonstrating the versatility of this system and approach29,30 
1.4 Innovation 
Given the need for patient-operated, solely smartphone-based approaches that can 
non-invasively replace blood-based diagnostics, I have developed a smartphone app that 
quantitatively analyzes patient-sourced photos to enable a noninvasive, accurate, and 
accessible anemia diagnostic that requires only the patient’s smartphone without the need 
for any additional equipment (i.e. smartphone attachments or calibration tools) or blood 
sampling. Here, a patient simply takes a picture of their fingernail beds, and the image 
analysis algorithm analyzes color data and image metadata to measure the corresponding 
Hgb level. This technology leverages the sophisticated imaging capabilities of existing 
smartphones to remotely diagnose and screen for diseases and encompasses several key 
innovations: 
1.4.1 This algorithm “learns” and improves the accuracy of Hgb level measurements 
as more data is collected. 
 As images are obtained and matched with gold-standard level Hgb levels, as is 
necessary for personally calibrated algorithms, the dataset used to generate and “train” 
the Hgb measurement algorithm expands. Increasing the size of the image dataset ensures 
that a more representative sample of the general population is utilized to develop the 
algorithm, improving the overall accuracy of the proposed technique. Furthermore, as 
more images are added to the dataset, more sophisticated algorithms are applied to 
 9 
facilitate this improvement. Thus, this innovative Hgb measurement method “learns” as 
the sample size increases. 
1.4.2 Smartphone incorporation facilitates patient-operated Hgb measurement. 
 Current technology used to measure Hgb levels requires a trained healthcare 
professional to operate. Existing POC technologies, designed to bring Hgb measurement 
from a clinical laboratory directly to the patient, are designed for  healthcare providers 
and none of these technologies are designed to be used at home by the patient as a self-
test. The technology I have developed leverages the ubiquitous worldwide ownership of 
smartphones with the user friendliness and familiarity of smartphone apps to develop a 
system that allows patients to conduct sophisticated blood testing themselves, without 
requiring a costly, inconvenient, and potentially cost-prohibitive clinic visit. Bringing 
anemia screening and monitoring from the clinic directly to the patient has the potential 
to fundamentally shift the treatment paradigm for those suffering from, or those at-risk 
for, anemia.  
1.4.3 Leveraging the sophisticated imaging capabilities of smartphones enables truly 
noninvasive Hgb measurement obviating the need for additional diagnostic 
equipment.  
Physical examinations of clinical pallor have long been used as a qualitative 
metric for diagnosing anemia. Various studies conducted in low resource settings have 
attempted to semi-quantitatively assess anemia by correlating physician assessment of 
clinical pallor with presence of anemia (defined at various blood Hgb level cut-offs)13-17. 
The system described in this thesis utilizes robust multi-linear regression to correlate 
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color and image metadata from smartphone images of fingernail data to specific Hgb 
levels, representing the first case of quantitative Hgb level measurement using only 
images, let alone smartphone images.  
1.4.4 Furthermore, personalized algorithm calibration allows for highly accurate 
monitoring of Hgb levels in those with chronic anemia conditions.  
Imaging a single patient over time in conjunction with CBC Hgb levels enabled 
this technology to establish personalized correlations between that individual’s fingernail 
bed color patterns and fluctuations and their Hgb levels. In this thesis, I present a method 
that will allow individuals suffering from chronic anemia to accurately monitor their 
anemia from the comfort of their home, potentially reducing costly clinic visits. This was 
accomplished by applying a personalized training scheme within algorithm development 
to improve accuracy. 
1.4.5 This work enables Hgb measurement to be conducted on and by anyone, 
anywhere in the world, at any time, using only a smartphone.  
The increasingly sophisticated imaging capabilities of smartphones coupled with 
their ever increasing worldwide ownership enables a powerful platform for image-based 
diagnostics. As no other software or hardware is needed, the system that I have developed 
obviates the need to visit a clinical setting to conduct testing. This fundamentally changes 
the treatment paradigm for individual’s suffering from anemia, and serves as a starting 
point to address the treatment of other conditions which manifest in physical signs and 
can thus be potentially diagnosed by imaging alone. Overall, these points highlight the 
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novelty and significant technical innovation of this work, and demonstrate the 
improvement of this technology over traditional anemia testing. 
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CHAPTER 2. BACKGROUND AND LITERATURE REVIEW 
2.1 Anemia 
2.1.1 Anemia Biology 
Anemia, characterized by low red blood cell (RBC) and blood Hgb concentrations, 
is the world’s most common blood disorder, afflicting nearly one-third of the world’s 
population, especially young children, the elderly, and women of childbearing age1,31,32. 
Due to numerous etiologies, including malnutrition, genetic hematologic diseases (e.g. 
sickle cell disease, beta-thalassemia), infections/inflammatory disorders (e.g., HIV, 
rheumatoid arthritis), cancer chemotherapy, and renal failure, anemia can become chronic 
and severe2,19-22. Left untreated, individuals suffering from anemia can suffer fatigue, 
weakness, cognitive disorders, and life threatening cardiovascular collapse in severe 
cases18. At-risk individuals, especially those with chronic conditions, therefore need to be 
regularly tested to prevent these symptoms and guide treatment strategies.  
Causes of anemia can be broadly grouped into the following categories: 
2.1.1.1 Impaired production of RBCs 
A primary cause of anemia is the inability of the body to produce sufficient levels 
of hemoglobin33. The most common cause of this inability to produce sufficient levels of 
hemoglobin is iron deficiency34,35. As iron is a key component to the production of red 
blood cells (erythropoiesis), a deficiency of iron can lead to the inability of the body to 
produce functional RBCs and, thus, hemoglobin36. The primary cause of iron deficient 
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anemia is poverty, malnutrition, and famine37. In these cases, patients are not able to 
absorb sufficient iron from their diet, inhibiting erythropoiesis. These problems are 
common in low-resource settings, and are the primary cause for the significant 
correlation between anemia and low resource settings. Furthermore, these issues with 
iron deficiency can also be caused by vegetarian diets, issues with absorption, and 
chronic blood loss due to menstruation, issues that impact developed countries in addition 
to low resource settings37. Once discovered, iron deficient anemia can be easily and 
relatively cost-effectively treated via dietary or intravenous supplementation, even in low 
resource settings38-41. This highlights the importance of knowing ones hemoglobin level, 
as small dietary alterations can lead to significant improvements in quality of life.  
 Furthermore, anemia related to insufficient production of RBCs can be caused by 
multiple hematological diseases, some of which can be chronic and severe. One example 
of such a disease is beta thalassemia major, a blood condition caused by a mutation in the 
hemoglobin molecule, preventing its synthesis2. This leads to inefficient production of 
RBCs. Individuals with this disorder require regular blood transfusions to treat their 
disease. This allows patients to replace their insufficient RBC production with the 
transfused RBCs. These patients require frequent monitoring in order monitor their Hgb 
levels to ensure their treatment strategies are working properly and to ensure that their 
hemoglobin levels do not drop below clinically significant levels. 
2.1.1.2 Increased Destruction of RBCs 
While inefficient production of RBCs can be responsible for anemia, the opposite 
is also true. Increased destruction of RBCs can also lead to anemia. Destruction of RBCs, 
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known as hemolysis, can be caused by a variety of disorders. The two most common 
mechanisms of hemolysis are intravascular and extravascular hemolysis. In intravascular 
hemolysis, RBCs are destroyed within blood vessels due to mechanical trauma caused by 
interactions with the vessel wall, complement fixation, and infectious agents42. The more 
common method, extravascular hemolysis occurs when RBCs are marked for destruction 
and destroyed in the vasculature of the spleen43. Disorders that can lead to hemolytic 
anemia include; hemoglobinopathies such as sickle cell anemia; immune disorders such 
as transfusion reaction due to ABO-incompatible transfused RBCs; drug induced 
hemolysis caused by drug coating RBCs and provoking an immune response; and 
infection such as when the malaria parasite leads to the weakening of the RBC 
membrane3,44-49. In all cases, premature destruction of RBCs leads to lower levels of 
usable hemoglobin, as the hemoglobin can no longer functionally carry oxygen within the 
vasculature after it has been expelled from the RBC50. It is very important for patients to 
understand track their hemoglobin levels when hemolysis is confirmed, as some of these 
conditions may lead to sudden severe drops in Hgb level that can lead to life threatening 
complications 
2.1.1.3 Bleeding 
The final, and most intuitive, cause of anemia is simply bleeding 51. In these 
cases, hemoglobin is simply being lost due to blood loss. Bleeding related anemia can be 
caused by either chronic or acute blood loss. Acute blood loss can occur for a variety of 
reasons, including injury, accidents, and surgery52. In these cases, it is important that 
patients monitor their hemoglobin levels after one of these events, as these events can 
lead to rapid, precipitous drops in hemoglobin that that can occur before a patient can get 
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to a clinic and have their Hgb levels measured. Chronic bleeding-related anemia can be 
caused by a variety of disorders, such as Von Willebrand disease, hemophilia, and 
gastrointestinal bleeding53-55. When bleeding is chronic, hemoglobin levels can gradually 
decrease overtime, and thus need to be monitored.   
2.1.2 Anemia Monitoring 
As a significant percentage of the world’s population is anemic, and each of these 
affected individuals requires anemia testing/monitoring, a number of methods have been 
developed to measure Hgb levels. 
2.1.2.1 Gold-standard anemia diagnosis 
Table 1: Noninvasive Hgb measurement compares favorably with currently-used 
anemia monitoring technology. 
Device Noninvasive External Device Free Inexpensive Accurate 
Complete 
Blood Count4 X X X  
Hemocue56 X X X  
Anemocheck6 X X   
HemaApp57  X  X 
Masimo Co-
Oximetry58  X X X 
Conjunctival 
Analysis24  X  X 
WHO Color 
Scale59  X  X 
Smartphone 
App     
The current gold-standard diagnostic test for anemia is the complete blood count 
(CBC), conducted via a clinical hematology analyzer4. The clinical hematology analyzer 
is extremely cost prohibitive, especially in resource poor settings, where anemia is the 
most prevalent worldwide. In order to conduct a CBC on a clinical hematology analyzer, 
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one must first purchase the machine and rent facilities to house and power it. A trained 
laboratory technician must be employed to run each test, which consumes reagents that 
must be purchased. Additionally, a complete blood count requires a venous blood draw 
from the patient, which requires employment of a second trained technician to administer, 
and can cause discomfort in patients, especially younger patients23.  
2.1.2.2 Point of care anemia diagnosis 
Due to the expense associated with the clinical hematology analyzer, point-of-care 
devices (i.e. devices that can be used at the time and place of patient care) have been 
developed to decrease costs and increase accessibility, particularly to resource-poor 
settings. These point-of-care devices, while more cost effective, bring about their own 
challenges. Photometry and colorimetry-based Hgb prediction methods, used in products 
such as the Hemocue and Anemocheck, typically require costly additional measurement 
tools to measure absorbance of various chemical reactions involving Hgb, in addition to 
requiring venous blood draws or finger sticks5,6. Hgb color scale methods such as the 
World Health Organization color scale are generally very cost-effective, but rely on 
human interpretation of color comparisons of a droplet of blood on paper to a printed 
color scale to estimate Hgb, leading to inaccurate Hgb estimations60. More sophisticated, 
non-invasive, spectrophotometric Hgb estimation techniques such as the Masimo Pulse 
Co-Oximeters, can accurately estimate Hgb, but these techniques are also cost-
prohibitive7. Digital imaging based technologies, including techniques utilizing 
smartphones, have been explored as a simple alternative, but results have been 
insufficient to replace blood-based testing25,57. These technologies and their associated 
drawbacks are summarized in Figure 2 and Table 1. 
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Figure 2: Current anemia monitoring technology. Traditionally, anemia is monitored via 
blood-based technologies in clinical settings. The gold standard anemia test is the complete 
blood count (top row), which requires a venous blood draw. Other calorimetric 
technologies have been developed that require less blood and may be used in POC 
applications, such as the Hemocue, WHO color scale, and Anemocheck (middle row). 
Other noninvasive technologies have also been developed that measure hemoglobin via 
light absorption or reflection off body regions, such as the HemaApp, Masimo Pronto, and 
conjunctival analysis in digital photographs (bottom row). 
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2.1.2.3 Qualitative anemia diagnosis 
 While the gold-standard anemia diagnostic test is an extremely useful tool in 
determining a patient’s treatment needs, physical examinations alone have long been used 
to aid in Hgb estimation. Multiple studies in low resource settings, where the gold 
standard anemia diagnostic tool is extremely cost prohibitive, have attempted to semi-
quantitatively estimate Hgb in patients using results from physical examinations13-17,61-65. 
Skin color is determined by the 3 major pigments; melanin, by far the most impactful; 
carotenoids, the least impactful; and Hgb66. In specific regions of the body, such as the 
fingernail beds, conjunctiva, and palmar creases, melanocytes (cells that lie within the 
epidermis and produce melanin) lie dormant67,68. This causes the blood Hgb levels to 
have the greatest impact on skin tone in these regions. Pallor in these regions generally 
corresponds to a lack of Hgb in the blood vessels near the epidermal surface, providing a 
pseudo-anemia diagnosis. In the previously mentioned studies, pallor of the conjunctiva, 
fingernail beds, and palmar creases was assessed by physicians, who then characterized 
patients as “anemic” (defined by varying Hgb concentration ranges from study to study) 
or not. These characterizations were compared with Hgb levels measured using the gold 
standard. Quantitative data (sensitivity and specificity) were reported based on the 
accuracy of the physician’s characterizations of anemia. While these findings were not 
able to accurately predict blood Hgb levels, they were successful enough to establish a 
correlation between clinical pallor and anemia and introduce physical examinations as a 
viable means to generally estimate Hgb. 
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2.2 mHealth diagnostic tools 
The utility of physical examinations in estimating Hgb facilitates remote imaging 
as a means for anemia diagnosis. Mobile phone ownership is increasing worldwide. 
Currently, there are approximately 4 billion unique mobile phone subscribers worldwide, 
representing over half of the world’s population9. In fact, there are more mobile phones in 
use than there are people worldwide, and half of those mobile phones are “smartphones”. 
The fastest growing market for mobile phone subscribers is in low resource settings, 
where anemia is most prevalent. These smartphones incorporate sophisticated imaging 
software into their design, which can potentially be utilized by medical apps.  
In fact, smartphones have been used in a variety of mHealth applications69. These 
apps can be classified into 3 major classes of devices or systems. 1) Apps that track 
medical record information and promote the maintenance of a healthy lifestyle, or 
facilitate patient-physician interaction and assist physicians with making a clinical 
decision; 2) apps that interface with an additional medical device and analyzes data or 
interprets a result; and 3) apps that use technology and computing power found on 
modern smartphones to turn the smartphone into a standalone medical device.  
Apps that track medical data and promote healthy lifestyle maintenance are the 
most common mHealth apps. A classic example of an app that promotes maintaining a 
healthy lifestyle includes diet apps which track the user’s body weight over time in order 
to assist the user in their goal of losing weight. These apps are also often used to gather 
and record sensitive medical data for the patient and physician. Examples of this include 
diabetes apps such as Daily Carb, which tracks key metrics for managing diabetes such as 
 20 
meal times and readings for carbs, fiber, fat, and glucose which can then be shared with a 
physician70. Apps in this category can also serve to augment the patient-physician 
interface by simply offering the ability to search for doctors based on symptoms or triage 
diseases based on a list of symptoms, such as with the services ZocDoc and WebMD71,72. 
These apps can also be used to improve patient compliance to medication usage as well 
as refill prescriptions. These applications have presented a challenge to the medical 
device regulatory body of the United States of America, The Food and Drug 
Administration (FDA), as technology to assist with these issues has traditionally fallen 
into the realm of medical devices, and the market has become flooded with these 
technologies73. The FDA has responded by allowing exemptions to regulatory oversite 
for applications that pose no significant risk to patients should they fail and that fall into 
the categories of physician support or healthy lifestyle maintenance software. 
Mobile app software that interfaces with external medical devices is another 
common mHealth modality. In fact, the majority of revenue generated by mHealth 
companies is driven by external device sales rather than in-app purchases74. A wide 
variety of technologies have been adapted to interface with smartphones, including such 
staple, sophisticated medical technologies such as echocardiograms, otoscopes, and 
pulse-oximeters. This enables direct collection, storage and transmission/communication 
of patient medical data directly to the patient’s electronic medical records (EMR) as well 
as the physician. Furthermore, these systems potentially empower patients to control their 
own healthcare, as some of these systems may make available sophisticated medical tests 
that are not traditionally available in POC settings. These systems may also be used to 
enable new diagnostics and research tools. For example, microscopes that interface with 
 21 
mobile phones enable analysis of patient samples remotely to look for conditions such as 
malaria. Also, microfluidic POC tests have been developed that interface with the camera 
on mobile phones to generate a readout, enabling remote and POC diagnosis of a variety 
of diseases. 
Finally, the third classification of mobile medical apps is the least common, yet it 
forms the basis of the technology presented in this thesis. Very few technologies exist 
that can usejust the features and computing power of mobile phones themselves to turn 
the phones into a standalone medical device. The most prominent example of such a 
system is smartphone apps that are used to treat and monitor skin lesions in the context of 
skin cancer. In these cases, apps utilize the standard smartphone camera to monitor and 
characterize skin lesions based on a number of attributes in order to determine the 
likelihood that the skin lesion is malignant75. These systems represent major advantages 
over the other categories of mHealth apps. Unlike healthy lifestyle maintenance apps, 
they have the capability to accurately perform a diagnosis of a disease based on real-time, 
patient collected data that did not require a clinic visit or in some cases, even a trained 
medical professional. Unlike apps which interface with external medical equipment, these 
systems do not require that the user purchase an expensive piece of equipment in order to 
conduct testing. In this thesis, I have leveraged the imaging capabilities and the 
ubiquitous worldwide ownership of mobile phones with the diagnostic capability of 
physical examinations alone to develop a novel, non-invasive, easy-to-use, external 
device-free, smartphone application for diagnosing anemiawith the smartphone functions 
as a standalone medical device.  
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2.3 Image analysis in mobile medical devices  
Traditionally, medical image analysis has been conducted by trained medical 
professionals using the human eye. The invention and improvement of sophisticated 
imaging modalities such as standard photography, magnetic resonance imaging (MRI), 
and computed tomography (CT), have enhanced the need for medical image analysis in 
the diagnosis and prevention of disease76. However, the large physical variability of 
various pathologies as well of the fallibility and potential fatigue of the human eye of 
medical experts necessitates automated image analysis via computation for more accurate 
diagnosis and classification of medical images. To that end, advances in central 
processing units (CPU) and graphics processing units (GPU) have enabled for complex, 
sophisticated computational image analysis, which has been able to pick up features in 
medical images that are missed by medical professionals. In some cases, knowing which 
features to look for is no longer a barrier to constructing a computational image analysis 
algorithm to extract features in medical images, as deep machine learning algorithms 
eliminate this need via automated algorithm training77,78. The only downside of these 
methods is that large datasets are typically required to validate that the algorithms truly 
work on all disease cases as opposed to overfitting to the limited cases they have been 
exposed to. Anemia represents an excellent case study in this field, as diagnosis of 
anemia may be conducted visually by looking for clinical pallor. Now, as camera 
technology has increased, image analysis of clinical pallor in medical images can be 
utilized to diagnose anemia from image. This method has led to the technology I present 
in this thesis in which sophisticated regression algorithms are incorporated into modern 
smartphones to diagnose anemia remotely using only a smartphone. 
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2.4 Patient populations requiring noninvasive anemia monitoring 
Anemia afflicts a large percentage of the world’s population, and instances of 
anemia are projected to increase. Anemia has many different causes that require different 
treatment approaches. Each distinctive cause of anemia can therefore lead to unique, 
innovative applications for this anemia diagnostic tool. Take, for example, resource-poor 
settings, where malnutrition is a major driver of anemia (Table 2)1,79. The lack of quality 
healthcare facilities in these low-resource settings makes field-accessible devices to 
perform analysis and diagnosis a necessity, indicating key beneficiaries of this 
technology80.  
Healthcare officials in low resource settings can use this Hgb level measurement 
technique as a means to inform the allocation of limited healthcare resources (Figure 3A). 
Healthcare workers will be sent out to areas where anemia is prevalent and screen the 
general population. This will allow patients suffering from anemia to be discovered who 
otherwise would not have been diagnosed due to lack of available resources, such as 
access to clinical hematology analyzers.  
Table 1: Anemia affects a significant percentage of the world’s population 
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Individuals at-risk for anemia in the general population can use this method as a 
general screening tool (Figure 3B). An at-risk individual could use this image analysis 
algorithm to screen themselves for anemia and seek medical treatment if necessary, rather 
than wasting time and incurring expense due to unnecessary hospital trips. As children 
are all screened for anemia at around 2 years of age, an image-based, non-invasive test 
would allow parents to self-screen their children, eliminating unnecessary clinic visits 
and painful blood tests81. Chronic lead poisoning in children, an issue causing profound 
developmental delays and currently making national headlines, also leads to anemia. This 
algorithm could theoretically be used to monitor the health of children in areas with 
tainted water supplies82.  
Figure 3: The non-invasive, image-based smartphone app for diagnosing anemia 
facilitates a wide range of use models. This Hgb estimation technique can 
potentially be used as a healthcare resource allocation tool in low resource settings 
(A), a screening tool for anemia in general population at risk for anemia (B), and as a 
monitoring tool for chronic anemia patients (C). 
Patient takes images 
on Smartphone 
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Finally, In the case of a chronically anemic patient suffering from a hematologic 
disease in a developed nation, this tool could be used to self-monitor and allow the 
patient and physician to track the efficacy of drug and diet therapies (Figure 3C). A 
patient could potentially take multiple images, and compare the results with gold 
standard-measured Hgb levels to calibrate the smartphone app to their specific fingernail 
characteristics. This calibration would allow for much more accurate Hgb level 
estimation, which would permit an individual suffering from a disease casing anemia as 
well as the physician treating them, to accurately monitor disease progression and 
treatment efficacy remotely.  The results of these tests could be used by the physician to 
remotely alter treatment regimens as necessary, without having to see the patient. A 
simple, non-invasive, inexpensive test for estimating Hgb levels has the potential to be 
used as a screening tool that has the capability to reach multiple user groups and improve 
the lives of patients suffering from a myriad of diseases.   
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CHAPTER 3. DETERMINE THE FEASIBILITY OF 
DEVELOPING AN IMAGE ANALYSIS ALGORITHM THAT 
CAN ACCURATELY PREDICT HGB VALUES FROM 
SMARTPHONE IMAGES OF SUBJECTS FINGERNAILS 
3.1 Introduction  
Physical examination alone has long been implicated in anemia diagnosis. 
Physicians have a long history of using physical examination of clinical pallor in a 
number of body regions including the conjunctiva, palmar creases, and the fingernail 
beds to qualitatively diagnose anemia15,63,83. These regions provide excellent anemia 
diagnostic capabilities becauset they do not contain melanocytes, the skin cells 
responsible for production of the pigment melanin and, thus, the skin tone of the 
individual67. As such, the primary contributor of skin color in these regions is Hgb (i.e. 
the molecule which gives blood its hallmark red color) of the blood flowing through the 
underlying vasculature. Thus, low Hgb levels lead to clinically observable pallor. 
Furthermore, as pallor is purely a color based phenomena, I and others have hypothesized 
that image analysis would be able to distinguish minute color variabilities related to Hgb 
fluctuations, such that Hgb level could be correlated with pallor57. Furthermore, I 
hypothesized that smartphone camera technology had become sufficiently advanced such 
that this correlation could be generated via smartphone images, leading to remote 
assessment of Hgb levels via a smartphone.  
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In this aim, I investigated the possibility of using the conjunctiva, fingernail beds, 
and palmar creases for assessing anemia via smartphone images, and determined the most 
appropriate body regions for conducting pallor-based Hgb analysis. In doing this, I took 
into consideration accuracy of results, ease of access to the body region, ability of an 
individual to self-image, and the computing power and user input necessary to identify 
the correct body regions of interest for analysis. Furthermore, in the process of 
identifying the optimal region of interest for correlating Hgb to pallor, I discovered a 
methodology for developing image analysis algorithms that can measure Hgb level based 
on color data from smartphone images of fingernails. In this chapter I report the 
reasoning behind choosing fingernail beds as the body region of choice for assessing 
anemia via smartphone images, the methodology for arriving at this choice, and the 
algorithm used to correlate fingernail color to Hgb level. 
3.2 Materials and methods 
3.2.1 Choosing a body region of interest 
In order to choose the best region of interest on the body to be used to relate 
clinical pallor to Hgb level, images were taken of three body regions commonly used to 
diagnose anemia via physical examination. The regions of interest used were the 
fingernail beds, the conjunctiva, and the palmar creases. In order to take images of the 
fingernail beds, subjects were instructed to curl their fingers inward in order to control for 
blood flow alterations caused by hand position. Images of the conjunctiva were taken by 
requesting that subjects use their index finger to pull down their eyelids to expose the 
conjunctive. Images of the palmar creases were taken by asking subjects to flex their 
 28 
hand outward, exposing their palms. All images were taken at a distance of 
approximately 0.5 m from the body region of interest. Red, green, and blue (RGB) pixel 
intensity color data was extracted from each regions of interest (ROI) within each image 
(corresponding to the body region of interest) and correlated with the gold standard-
measured Hgb level of the subject. All images were taken with an Apple iPhone 5s 
(Apple, Cupertino, CA) using all default imaging settings. 
3.2.2 Algorithm Development 
In order to develop the Hgb estimation algorithm, average RGB pixel intensity 
data from ROIs within a single patient’s fingernail beds were extracted from the 
smartphone images via a custom generated MATLAB (Mathworks, Natick, 
Massachusetts) function. This patient suffered from β-thalassemia, causing well defined 
fluctuations in Hgb level that could be used to correlate with pallor. Average pixel 
intensity values from the 3 color channels (RGB channels) were correlated with the gold-
standard measured Hgb levels. I served as the initial patient in this proof of concept 
study, as my hemoglobin levels fluctuate rapidly and predictably due to a genetic blood 
condition that I am afflicted with (β-thalassemia major).  
3.3 Results and Discussion 
3.3.1 Fingernail beds are the optimal region of interest on the body for relating clinical 
pallor to presence of anemia. 
In order to develop an image analysis algorithm that measures Hgb based on 
clinical pallor, an appropriate body region must be selected. This region must be known 
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to exhibit pallor when an individual is anemic, and must be easy to image. Three 
candidate body regions were chosen for this study, corresponding to an individual’s 
conjunctiva, palmar creases, and fingernail beds (Figure 4). The conjunctiva was the first 
body region studied, as it is commonly used to diagnose anemia via a physical 
examination. During imaging and data collection, it was difficult to collect RGB color 
data from the regions of interest for a number of reasons. First, it was difficult to explain 
to a subject exactly how far they need to pull their eyelid down in order to expose the 
conjunctiva. Furthermore, every individual tested pulled down their eyelid with different 
force, exposing different amounts of conjunctiva. This variability among individuals 
makes data extraction difficult as the region of interest changes drastically from person to 
Figure 4: Images of various body regions associated with anemia. Images were taken 
of the A) conjunctiva, B) palmar creases, and C) fingernail beds in order to correlate 
pallor with Hgb level. A-B) These images highlight the issues with self-imaging of the 
conjunctiva, as well as the variability of the palmar creases. C) Furthermore, these 




person. Also, looking towards implementation in a standalone smartphone app self-test, it 
is quite difficult for an individual to expose their conjunctiva and simultaneously take an 
image of it. For these reasons, the conjunctiva was ruled out as a region of interest for 
hemoglobin measurement. The next region of interest studied was the palmar crease. The 
palmar creases were difficult to analyze due to the fact that each individual had a 
different pattern of creases in their palms84. This would necessitate the development of a 
custom algorithm to identify each subject’s palmar creases in order extract data from, a 
fact which immediately disqualified its use for anemia measurement. Finally, the 
fingernail beds were investigated as a region of interest for Hgb level measurement. 
While finger physiology varies slightly between individuals, the fingernails provide a 
consistent imaging window for the most part. These imaging windows are relatively 
large, facilitating simple RGB color data extraction from them. Furthermore, it would 
potentially be very easy for a user to use one hand to hold a smartphone and take an 
image of the fingernail beds on the other hand. For these reasons, the fingernail beds 
were ultimately chosen as the body region of interest for relating clinical pallor to 
anemia.  
3.3.2 A Proof of concept study reveals that fingernail color is correlated to Hgb level in 
a chronically anemic and transfused β-thalassemia patient. 
The proof of concept study for this project involved observing the fingernail bed 
color of a patient with a chronic hemolytic anemia disorder (β-thalassemia major) 
requiring RBC transfusion therapy.  β-thalassemia is a chronic genetic disease caused by 
a mutation hindering or preventing synthesis of the β chain of Hgb, the blood’s oxygen 
transporting molecule2. This inhibited Hgb synthesis leads to insufficient oxygen 
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transport in the patient’s body. Treatment for this condition requires RBC transfusions to 
make up for the patient’s insufficient Hgb production2. Over time, as the donated red 
blood cells are naturally destroyed by the body, the patient’s blood Hgb levels drop. This 
drop continues until the patient’s blood Hgb levels reach a clinically significant threshold 
(~10 g/dL), at which time the patient must receive another transfusion to avoid the 
manifestation of anemia symptoms. A patient suffering from β-thalassemia major 
represents an ideal test case for the hypothesis that Hgb levels can be accurately predicted 
using a strictly physical examination-based method due to the fact that their Hgb levels 
fluctuate very predictably through a wide concentration range over a relatively short 
period of time.  
In this proof-of-concept study, images were taken on a smartphone of the 
patient’s fingernail beds (Figure 5A) over the course of 3 weeks (corresponding to 1 
Figure 5: A non-invasive, image-based algorithm accurately predicts blood Hgb 
concentrations of chronically anemic patients. A) Representative patient image used 
to predict anemia. B) The predicted Hgb levels strongly correlate with Hgb levels 
determined by a clinical hematology analyzer (r2 = .995) in a chronically anemic beta 
thalassemia patient over the course of several weeks after receiving a red blood cell 
transfusion.  
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transfusion cycle) and blood Hgb levels were estimated by correlating the “blue” channel 
pixel intensity to the patient’s actual blood Hgb levels. These estimations were compared 
to blood Hgb levels measured via the gold standard blood test. Images and blood samples 
were taken 1 day post-transfusion (week 0), 1 week post-transfusion, 2 weeks post-
transfusion, and 3 weeks post-transfusion (1 before the next transfusion cycle began). 
Hgb level estimates were able to be strongly correlated (r2 = 0.995) with gold standard-
measured Hgb levels (Figure 5B). The results from this study indicate that this technique 
can be used to successfully and accurately measure a single patient’s hemoglobin levels. 
This proof-of-concept result served to legitimize my hypothesis that imaging fingernails 
alone is sufficient to measure blood Hgb concentration and opened the door of the future 
validation experiments presented in this thesis. 
3.4 Conclusions and alternative approaches 
Practical reasons presented in this chapter highlight the reasoning behind 
choosing the fingernail beds as the optimal region of interest on the body for relating 
clinical pallor to anemia. In addition to practical reasons relating to data extraction, the 
intended use of this technology was considered to exclude regions that are difficult to be 
self-imaged by an individual. Furthermore, quantitative data regarding the correlation 
between color data and gold standard-measured Hgb level presented in this proof-of-
concept study showed that Hgb levels could be successfully estimated using only 
smartphone images taken of fingernail beds. Linear regression was used to relate blue 
pixel intensity value to gold-standard measured Hgb level.  However, a major 
disadvantage of this proof-of-study is that the study was conducted on 1 subject. While I 
showed that Hgb levels could be accurately predicted, this study neglected many possible 
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confounding variables between different individuals that could affect Hgb estimation 
such as, imaging variability (e.g.  imaging parameters such as the angle at which an 
image was taken, the distance from the subject, and the type of camera used to take the 
image), skin tone, background lighting, and nail size. These potential sources of 
variability are addressed in the following chapter, where a large scale clinical study was 
conducted to collect more data that encompassed a better representation of the anemic 
population who could potentially benefit from this tool. However, the data presented in 
this chapter proves that this is a viable technique for measuring Hgb levels. 
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CHAPTER 4. VALIDATE AND IMPROVE THE ANEMIA 
MONITORING ALGORITHM WITH A LARGE SCALE 
CLINICAL ASSESSMENT 
4.1 Introduction 
In order to validate the image analysis algorithm that relates fingernail color to 
Hgb level, more data needed to be collected from many different individuals in order to 
account for variability between individuals. Fingernail color can vary between 
individuals for a number of reasons, including thickness of the fingernail, abnormal 
discolorations (e.g. leukonychia, melanonychia, and bruising), and lighting conditions 
under which fingernail images are taken85. As proof of concept studies used to develop 
the algorithm relied on data collected from a single individual, parameters related to 
variability could not be included in the model. This caused a situation known as 
overfitting, where the model describes a given situation perfectly, but inadequately 
describes alternate situations. In this case, the image analysis algorithm developed in the 
proof of concept study was able to accurately measure Hgb in the single individual, but 
would be likely less successful if applied to a wider population exhibiting fingernail 
variability. In addition to being able to accurately account for variability within a 
population, increasing sample size enabled the usage of more sophisticated correlation 
algorithm, including multi-linear regression and machine learning techniques such as 
neural networks.  
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In this chapter, I detail a clinical validation study in which I increased the sample 
size of the dataset used to correlate fingernail color with Hgb. In addition to increasing 
the dataset, I discuss the techniques used to improve the algorithm to fit the larger sample 
size, and I discuss the ability of the algorithm to account for many common sources of 
variability in images of fingernail beds. 
4.2 Materials and methods 
4.2.1 Clinical Assessment of Noninvasive Technique for Estimating Hgb Level  
A clinical assessment was conducted at Children’s Healthcare of Atlanta, Emory 
University of School of Medicine, and Georgia Institute of Technology to relate 
fingernail bed color to Hgb levels. Patients with various anemia etiologies scheduled to 
have their Hgb levels measured via a CBC as part of their clinical care were recruited to 
this study (n = 265). Subjects were excluded by quality control measures if their images 
showed fingernail beds that were obscured or discolored due to leukonychia, nailbed 
injury, nail polish, darkening due to medication86, etc. Exclusions were conducted to 
eliminate unnecessary variables that could obfuscate algorithm development. All CBC’s 
were conducted using blood samples collected via venous blood draw. Verbal and written 
consent and assent were obtained from subjects and their parents (age permitting) in 
accordance with the Emory University Institutional Review Board (IRB) (00081226) and 
the Health Insurance Portability and Accountability Act (HIPAA) regulations prior to 
partaking in the study. After samples of patients’ blood were collected to conduct their 
CBCs, two images were taken of those patients’ fingernail beds. Smartphone pictures 
were obtained with the camera flash both on and off. All images were taken with an 
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Apple iPhone 5s using all default imaging settings. Prior to imaging, the auto-focus and 
brightness adjustment of the smartphone camera was activated by tapping the screen in 
the region of interest (i.e. the fingernail beds) in order to focus on the nailbed. To ensure 
consistent images, each image was taken with the smartphone at a distance of 
approximately 0.5 m from the subjects’ fingernail beds. Subjects were instructed to curl 
their fingers inwards with their palms facing upwards to control for possible alterations in 
blood flow caused by hand and finger positioning that could potentially affect the 
underlying color of the fingernail beds. Images were taken in clinic examination rooms, 
Figure 6: Hgb level and skin tone distribution of the study population. A) Subject’s 
Hgb levels ranged between 5.9 g/dL and 16.8 g/dL. B) Subject skin tone was normally 
distributed.   n = 337 subjects. 
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where lighting conditions and room illuminants were relatively consistent. A digital light 
meter (Hisgadget, Union City, CA) was placed next to the subjects’ fingernail beds to 
further ensure consistent background lighting conditions. Measurements taken from this 
external digital light meter were recorded to monitor background lighting conditions but 
were not incorporated into the Hgb level calculation. An additional 72 healthy subjects 
from Emory University and the Georgia Institute of Technology were tested using an 
identical protocol in order to ensure the Hgb level distribution of the study population 
better reflected the general population. CBCs were conducted on each subject prior to 
imaging and were analyzed via the same clinical hematology analyzer (Advia 2120i, 
Siemens, Berlin, Germany) used in the clinical study. All imaging was conducted in a 
room with similar lighting conditions to the clinic exam rooms, which was confirmed via 
digital light meter. Fingernail bed images and blood Hgb levels were analyzed in a total 
of 337 subjects. These subjects’ blood Hgb levels ranged between 5.9 g/dL and 16.8 
g/dL, (Figure 6A). Subjects’ ages ranged between 1 and 60 years old. 167 female subjects 
and 170 male subjects were enrolled in this study. In 6 cases, fingernail polish was 
discovered after informed consent had been obtained, and these subjects were excluded 
from testing after study enrollment. In 1 case, an image labeled as having been taken with 
the camera flash on was discovered to have been taken with the flash off, resulting in this 
subject’s data being excluded.  
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4.2.2 Algorithm Development/Image Processing  
Smartphone images were transferred or transmitted from the smartphone used in 
the study to a computer. Fingernail data, skin color data, and image metadata (i.e. data 
describing the camera settings at the time the image was taken) were extracted from 
fingernail bed smartphone images via MATLAB (Mathworks, Natick, MA). ROIs from 
which fingernail and skin color data were extracted were manually selected to ensure that 
fingernail irregularities were excluded from analysis. These ROI were selected from each 
finger excluding the thumb, and were 900 pixels2, corresponding to approximately 10 
Figure 7: Color variability of fingernail beds is minimal across different fingers in 
the same individual. Color values in the red, green and blue channels were normalized 
to the second finger in each subject in order to compare color values from different 
subjects which were different due to variability within the study population. Fingers 3, 
4, and 5 (the thumb was excluded from Hgb measurement) show little difference 
compared to finger 2. No statistically significant difference between color values across 
different fingers was found (p > 0.30 in all cases). Statistical significance was 
determined via two-tailed Student’s t-test assuming unequal variance.  n = 10. 
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mm2 on the fingernail. The thumb was excluded due to the awkward hand position 
required to include the thumb in pictures. Color data was extracted from each region and 
averaged together across fingers for each subject. This was shown to be an acceptable 
method due to the low color variability between different fingers (Figure 7). An 
algorithm was then written in MATLAB utilizing robust multi-linear regression with a 
bisquare weighting algorithm to relate the image parameter data to CBC Hgb levels for 
each patient87.  
A uniform bias adjustment factor was also added to address the inherent 
variability in fingernail measurement. Two distinct use models and algorithms were 
applied for this Hgb measurement method: 1) a noninvasive, smartphone-based anemia 
screening test that does not require calibration with CBC Hgb levels, and 2) a 
noninvasive, smartphone-based, quantitative Hgb level diagnostic requiring calibration 
with CBC Hgb levels that enables chronic anemia patients to self-monitor their Hgb 
levels. Sampling strategies were used to generate the algorithm depending on the specific 
application. 
4.2.2.1 Anemia Screening among the General Population 
To develop the algorithm as a tool to screen for anemia, the entire study 
population (337 subjects) was randomly split into a “training” group (237 subjects) and a 
“testing” group (100 subjects). The training group was used to establish the relationship 
between image parameters and Hgb levels via robust multi-linear regression, much like 
the calibration phase of the personalized calibration study. A testing group of 100 
subjects was used to validate the resultant algorithm. Validation was performed by 
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applying the smartphone algorithm to each testing image and comparing the algorithm 
generated Hgb result with the CBC Hgb result (i.e. determining the residual of the 
algorithm-based method). This process was iterated 1000 times with different randomly-
selected without replacement training/testing groups to minimize residual error, thereby 
optimizing the parameters of the algorithm for anemia screening. Hgb measurements 
taken from the previously described personalized calibration study were not included in 
this anemia screening study. 
4.2.2.2 Personalized Calibration of Smartphone Processing System 
A personalized calibration approach was tested in two β-thalassemia major 
patients with chronic anemia currently undergoing chronic transfusion therapy, a healthy 
female subject with Hgb levels that fluctuated during her menstrual cycle, and a healthy 
male subject with consistent Hgb levels over an identical timeframe to assess the 
algorithm’s capability to be accurately personalized and calibrated to that individual, 
regardless of their diagnosis or Hgb levels. Treatment for β-thalassemia major currently 
comprises of red blood cell transfusions to compensate for the patient’s ineffective 
erythropoiesis2. Hgb levels in the chronic anemia patients fall throughout a 4 week 
transfusion cycle which was chosen as an appropriate time interval for this study. Prior to 
each imaging session, CBC Hgb levels were obtained from each subject via venipuncture.  
Color data and phone metadata were compiled, and a relationship between image data 
and CBC Hgb levels was established via robust multi-linear regression. This process was 
repeated for each individual using data from the 4 weeks of images to create a unique 
calibration curve personalized for that individual. This initial 4 week period is analogous 
to the “training” phase of the general population study, in which a personalized algorithm 
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is trained for each subject. Image parameter changes associated with Hgb level 
fluctuations specific to each person were related to perform algorithm calibration specific 
to each subject, thus improving the accuracy of Hgb level estimation. After the 
smartphone image analysis system was calibrated for each subject, Hgb levels were 
measured weekly over the next 4 weeks using the newly personalized algorithm. These 
Hgb level measurements were then compared to the CBC Hgb levels obtained at the same 
time to assess accuracy. This second 4 week interval corresponds to the testing phase of 
the general population study. This personalized calibration occurred over a total of 8 
weeks. 
4.2.3 Statistical Analysis 
Statistical significance (p < 0.05) was determined via two-tailed Student’s t-test 
assuming unequal variance. All statistical tests (calculation of regression correlation 
coefficients and Student’s t-tests) were conducted using Origin Pro 2017 student version 
(OriginLab Corporation, Northampton, MA).  
4.2.4 Study Approval 
The clinical study regarding the application of the Hgb measurement algorithm 
was approved by the Emory University IRB (approval number 00081226). The study 
regarding the relation of finger temperature and exercise to measurement error was 
approved by the Georgia Institute of Technology IRB (approval number H17118) 
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4.3 Results and Discussion 
4.3.1 Variation between images of multiple individuals inhibits Hgb estimation based 
simply on one parameter.  
The previously described method using linear correlation to relate blue channel 
pixel intensity to Hgb obtained in the β-thalassemia major patient study was applied to 
fingernail bed data from a group of healthy individuals (Figure 8A) in order to estimate 
their Hgb levels. These results did not show any significant correlation between blue 
pixel intensity and gold standard measured Hgb, indicating the presence of confounding 
variables within the experiment introduced by observing a larger population (Figure 8B). 
I hypothesized that these variables could potentially have arisen from the differences in 
skin tone between the individuals, differences in the fingernail physiology of each 
individual (such as fingernail thickness), and subtle differences in the lighting conditions 

















Figure 8: Variabilities within the tested population obscures Hgb level estimation. 
A) Images of the fingernail beds of a random sample of study subjects. Each image was 
taken using the same imaging conditions. However, lighting conditions and subjects’ 
skin tones vary substantially between each image. B) When including a larger, more 
diverse sample population, blue channel pixel intensities show no correlation to 
goldstandard measured Hgb levels. 
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present at the time the images were taken. This prompted future experiments 
investigating the impact that skin tone has on Hgb level measurement, detailed in the next 
chapter. 
4.3.2 Blood Hgb levels were accurately estimated in a group of healthy individuals and 
anemic patients at Children’s Healthcare of Atlanta (CHOA) and the Georgia 
Institute of Technology.  
Given my initial failure to correlate the average pixel intensity of a single color 
channel to blood Hgb levels in a larger, more diverse, population I decided to extract and 
explore other parameters from images of fingernails. To test this hypothesis that 
differences in skin tone and lighting conditions between diverse populations, I explored 
parameters related to these issues. In addition to looking at just RGB color data within the 
fingernail beds, I incorporated RGB color data from a control patch of skin located 
between the first and second knuckles on the middle finger.  
This introduced skin tone as a variable in the model, allowing the algorithm to 
normalize for different skin tones. I believed that this a valuable model parameter due to 
the fact that different skin tones can relate to different pigmentation levels within 
fingernail beds.  For example, melanocytes, which typically lie dormant within the 
fingernail beds, are more likely to actively produce melanin in individuals with darker 
skin tones68. In order to normalize for differences in lighting and imaging conditions 
between each image, metadata was extracted from each individual image file. Parameters 
extracted from the image metadata are used by the algorithm to correct for differences in 
external lighting conditions.  
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Adding additional parameters to the model increased the model’s complexity. 
This increased complexity, while computationally expensive, had the potential to 
decrease the error (defined as the difference between the estimated Hgb level and the 
gold standard-measured Hgb level) in the Hgb measurement algorithm, as it encompassed 
more variables related to fingernail pallor in the general population. However, increasing 
the complexity of the model also increased the likelihood of overfitting the data, 
potentially leading to inaccurate Hgb level estimation. Overfitting occurs when ratio of 
model parameters relative to the number of observations is too high88. A perfect fit could 
potentially have been generated to the study subjects available. If applied to a larger 
population, however, the fit that worked well for the study size may not have accurately 
represented the larger population.  In order to obtain a sufficient sample size of subjects 
to prevent overfitting due to the addition of multiple parameters to this image analysis 
algorithm89, I conducted a large-scale clinical study at Children’s Healthcare of Atlanta 
(CHOA).  
4.3.3 Multiple linear regression was used to relate parameters extracted from clinical 
study-derived images of fingernail beds to blood Hgb levels. These relationships 
were used to develop a prediction algorithm for estimating anemia. 
  Multiple linear regression was used to model the relationship between the 
previously described parameters (independent variables) and blood Hgb concentrations 
(dependent variable)90. The ordinary least squares method was used to estimate this 
relationship91. This method finds coefficients that, when multiplied by each unique 
parameter and linearly combined, minimize the difference between the estimated variable 
and the observed variable determined via gold standard Hgb estimation (1). A bisquare 
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weighting algorithm was used to dampen the effects outliers have on the model, using a 
technique known as robust linear regression (2)87. Testing this method required splitting 
up the subject pool into randomized “training” and “testing” subject groups. The data 
from the training subject pool was used to model the relationship between the image 
parameters and Hgb concentrations as previously described. Once the relationship was 
established and a prediction algorithm determined, the relationship was applied to the 
testing subject group to attempt to predict their Hgb levels without using the gold 
Figure 9: Increasing the size of the “testing” sample pool relative to the “training” 
pool increases error and bias in the prediction algorithm. A) 10, B) 20, C) 50, and D) 
150 images were randomly selected and held aside from images of n = 273 subjects taken 
with the camera flash on. The prediction algorithm was trained with the remaining 
samples and the fit was tested on the held aside sample images. This process was 
repeated 1000 times and the best-case-scenario is shown. Average error of 1000 trials = 
~1.5 g/dL in all cases. Solid line represents ideal prediction of predicted Hgb level = 
measured Hgb level. Dashed line indicated linear fit of the data. Decrease in slope of 
linear fit from ideal fit indicates experimental bias. 
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standard data. The data presented here shows the predicted Hgb values of the testing 
group plotted against the gold standard-estimated values (Figure 9). This process was 
repeated 1000 times to ensure that luck did not play a factor in “guessing” random 
images that happened to correlate better than others due to inadvertent experimental 
variability. In the best-case scenario, the prediction algorithm can estimate the blood Hgb 
concentration of 10 patients to within 0.52 g/dL (Figure 9A). Increasing the size of the 
training subject pool relative to the testing subject pool leads to an increase in the error of 
the best-case scenario observation, leaving the accuracy of the average of 1000 random 
iterations nearly identical at ~1.5 g/dL (Figure 9A-D). This indicates that the clinical 
study was of a sufficient sample size due to the fact that increasing the number of trained 
observations had little impact on the overall accuracy. As I increased the size of the 
testing pool relative to the training pool, the error in the best case scenario increased. 
However, with a sample size of n = 150, representing >50% of the total number of 
subjects, it was possible for the algorithm to predict Hgb levels to within 1.3 g/dL, a level 
of accuracy approaching that of similar, more expensive devices (Figure 9D)92. In 
addition to observing an increase in the error of the best-case-scenario as size of the 
testing pool relative to the training pool is increased, I observed a decreased slope in the 
linear fit. The practical implication of this observation is that subjects who have very high 
or very low Hgb levels are being predicted closer to the population’s mean Hgb level 
than they should be. This indicates the presence of bias in the experiment.   
 
𝐻𝐻𝐻𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 =  �𝐶𝑃 ∗  𝑃𝑃
𝑃
𝑃=1
  (1) 
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Where n is the number of parameters in the model, Pi…Pn represents each 
parameter in the model, and Ci,…  Cn represents the coefficient relating each parameter to 
the gold standard Hgb estimation.  
Figure 10 Correction factors reduce the impact of experimental bias on the Hgb 
prediction algorithm. A - Top) Predicted Hgb levels of 150 subjects were reported. A-
Bottom) The slope of the linear fit of the data points in the Bland-Altman plot (bottom) is 
positive, indicating presence of experimental bias. B-C Top) Correction algorithms do not 
significantly alter error in the prediction algorithm. B-C Bottom) Correction algorithms 
reduce slope in the bland Altman plots, indicating mitigation of experimental bias. Top) 
Solid lines indicate ideal fit of measured Hgb level equals predicted Hgb level. Dashed 
lines indicate actual linear fit. Bottom) Hgb level difference is defined as the difference 
between predicted Hgb level and measured Hgb level of a subject. Mean Hgb level is the 
average of the predicted and measured Hgb levels for a subject. Solid black lines indicate 
95% limits of agreement (1.96 x Standard deviation of the Hgb difference). Solid red lines 
indicate mean Hgb level difference.  Dashed lines indicate actual linear fit. 
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 𝑤𝑤𝑤𝑤ℎ𝑡 = ( 𝑎𝑎𝑎(𝑟) < 1) ∗ (1 − 𝑟2)2          
𝑊ℎ𝑤𝑟𝑤 𝑟 =  
𝑤𝑟𝑟𝑒𝑟
𝑡𝑡𝑡𝑤 ∗ 𝑎 ∗ √1 − ℎ
 
(2) 
Where error is the difference between the predicted Hgb level and the gold 
standard estimated Hgb level, h represents leverage values from a least-squares fit, tune is 
the default tuning constant, and s is the standard deviation of the error.  
4.3.4 Transforming the prediction algorithm data partially corrects for the 
experimental bias without sacrificing accuracy 
In order to address the observation that subjects with Hgb levels near the 
boundary of the population’s Hgb range tend to be predicted closer to the mean (i.e. 
predicted too high near the low end of the range and too low near the high end of the 
range), I applied transformations to the original Hgb measurement data (Figure 10A) in 
an attempt to accurately predict Hgb levels across the entire range of Hgb levels. A linear 
(3) (Figure 10B) and sigmoidal (4) (Figure 10C) correction algorithm based on the 
predicted Hgb level distance from the population mean was applied to the results from 
the prediction algorithm on 150 subjects. Both correction factors reduced the bias, as 
shown by the reduction of slope in the Bland – Altman plots (a plot primarily used to 
illustrate compare the performance of a new method to the gold standard), while 
preserving the error (Figure 10Bottom)93. While this represented an improvement in the 
prediction algorithm, this correction did little to address the cause of the bias in the data.  
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 𝐻𝐻𝐻𝐶𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 =  𝐻𝐻𝐻𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 +  (𝐻𝐻𝐻𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 − 𝐻𝐻𝐻𝑀𝑃𝑀𝑃) (3) 




Where n = max value of transformation, and 𝑥 =  𝐻𝐻𝐻𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 − 𝐻𝐻𝐻𝑀𝑃𝑀𝑀𝑀𝑃𝑃𝑃 
4.3.5 Altering the testing and training protocol to account for Hgb level distribution 
decreases error and reduces experimental bias. 
I hypothesized that the experimental bias leading to large error at the boundary of 
the study population’s Hgb level range could be due to the Hgb level distribution in the 
study population. Due to the nature of their conditions requiring treatment at CHOA, the 
majority of the study subjects were mildly anemic. Training populations were randomly 
selected from the study population to develop the prediction algorithm; therefore, the 
prediction algorithm was trained based on data that had a clear anemic majority. I 
believed that the least squares algorithm was being solved in a way that fits the 
predictions to the training data set. In other words, Hgb measurement data was flawed 
due to the flawed Hgb level distribution of the training data. I amended the protocol for 
selecting training samples from the study population to investigate this hypothesis. The 
study population was broken up into 3 groups based on gold standard-measured Hgb 
level (<9 g/dL, 9 – 12 g/dL, and >12 g/dL). An equal number of subjects from each group 
was randomly chosen to train the algorithm using the previously described method. This 
ensured a constant Hgb level distribution among the training population. The resulting 
prediction algorithm was applied to the remaining subjects. This training method was 
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successful, resulting in an average error of 0.89 g/dL in 100 patients and a reduction in 
bias (Figure 11). 
Figure 11: Training population Hgb level distribution affects accuracy of the Hgb 
prediction algorithm. A) Hgb level predictions of 100 subjects tested using a prediction 
algorithm trained with a subject group possessing normally distributed Hgb levels 
(Top). The slope in the Bland-Altman plot (Bottom) indicates experimental bias. B) 
Hgb level prediction of 100 subjects tested using a prediction algorithm trained with a 
subject group possessing uniformly distributed Hgb levels (Top). When trained with a 
population possessing a uniform Hgb level distribution, average error decreases (Top), 
and bias is reduced (Bottom) relative to a normally distributed training population. Top) 
Solid lines indicate ideal fit of measured Hgb level equals predicted Hgb level. Dashed 
lines indicate actual linear fit. Bottom) Hgb level difference is defined as the difference 
between measured Hgb level and predicted Hgb level of a subject. Mean Hgb level is the 
average of the predicted and measured Hgb levels for a subject. Solid black lines 
indicate 95% limits of agreement (1.96 x Standard deviation of the Hgb difference). 
Solid red lines indicate mean Hgb level difference.  Dashed lines indicate actual linear 
fit. N = 100. 
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4.3.6 Skin tone has little impact on error in Hgb level estimation 
I hypothesized that another potential cause of the observed experimental bias 
stems from the fact that individuals with darker skin tones are more likely to have 
abnormally pigmented fingernail beds68.  I employed automated analysis of skin tone to 
account for this. The CIELAB color space was designed as a device independent color 
space capable of approximating human vision94. Much like the human brain, this color 
space distinguishes between light and dark (“L” value), between red and green (“A” 
Figure 12: Skin tone has negligible impact on Hgb estimation error. A) Difference 
and B) absolute difference of Hgb levels show a weakly positive correlation to skin tone 
(shown on a 0 to 100 scale with 0 being absolute dark skin tone and 100 being absolute 
light skin tone. Hgb estimation algorithms trained with subjects possessing C) dark or D) 
light skin tones show minor difference in error. Dashed lines indicate linear fit. Solid 
lines indicate ideal fit of predicted Hgb level equal to measured Hgb value. 
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value), and between blue and yellow (“B” value), by using a transformation on the RGB 
values in each image based on the illumination source of the image. The lightness, or “L” 
value, most accurately represents human perception of skin color and serves as an ideal 
variable linearly modeling skin tones in a population95. Using these non-biased skin tone 
values, I investigated whether a subject’s skin tone had any correlation with the error 
associated with the Hgb level prediction for that subject. I found that the “L” value of a 
subject’s control patch of skin, in which a higher value correlates to lighter skin tone, had 
little impact on the absolute Hgb level difference with a weakly positive correlation 
between lighter skin and greater Hgb level and absolute Hgb level difference (Figure 
12A-B). I also amended the training group selection procedure once more to determine if 
grouping subjects by skin tone could lead to more accurate predictions algorithms based 
on skin tones. Subjects with light skin tones and dark skin tones were grouped together 
and the previously described training/testing procedure was conducted on each group. 
Here I show that the error associated with the algorithm trained with individuals with 
dark skin tones was nearly identical to the error associated with the algorithm trained 
with individuals with light skin tones (Figure 12C-D). These results indicate that 
melanocyte activity and subsequent pigmentation of the fingernail beds and, thus, skin 
tone did not play a significant role in the observed experimental bias in this Hgb level 
estimation procedure. 
4.3.7 Machine learning techniques do not improve Hgb level measurement accuracy 
given the current sample size of the study population. 
While the accuracy of Hgb measurement that I have reported is within clinically 
acceptable levels for a POC device, more sophisticated regression methods were 
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investigated in an attempt to improve Hgb measurement. In order to assess the viability 
of more sophisticated Hgb measurement models, Hgb measurement was conducted using 
2 methods of machine learning that are capable of determining unanticipated non-linear 
relationships between fingernail data and Hgb levels. Neural Network regression utilizes 
a network of hidden nodes that can approximate nonlinear relationships between a set of 
input parameters96. Using a training set of inputs (fingernail bed image parameter data) 
and outputs (gold standard measured Hgb levels), a “learning” algorithm utilizing 
Levenberg – Marquardt backpropagation and implemented in MATLAB was used to 
model the relationship between fingernail bed image parameters and gold standard-
measured Hgb levels. This relationship was tested on a group of 100 images to estimate 
their Hgb levels, similar to the training and testing procedure outlined previously in this 
aim using linear regression. Using this method, the Hgb estimation error increases to 
1.6g/dL as compared to robust multi-linear regression (Figure 13A-B). Bagged decision 
tree ensemble regression utilizes multiple decision trees corresponding to different 
subsets of features (fingernail bed parameters in this case) trained on small random 
groups of the overall training set (i.e. the image pool), a technique known as bootstrap 
aggregation, and averaging the regression results of the different trees in order to reduce 
overfitting97. When this method was applied to a testing image group, the Hgb estimation 
error increased to 1.26g/dL compared to the robust multi-linear regression case (Figure 
13A,C). This indicates that neither method has improved upon the success of the simple 
robust linear regression model. However, the Hgb level distribution of the training group 
in all three cases was normally distributed, which I have shown to be less effective than a 
uniformly distributed Hgb level distribution.   
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4.3.8 Anemia Screening Using the Smartphone Image-based Algorithm when additional 
subjects are included to normalize Hgb level distribution 
This system has the capacity to serve as a noninvasive anemia self-screening tool 
for use by the general population or at risk populations. With a single smartphone image 
and no personalized calibration step, smartphone Hgb levels were measured to within 
±2.6 g/dL with a bias of 0.0 g/dL of CBC Hgb levels in 100 patients mixed with healthy 
subjects (Figure 14A, r = 0.79; Figure 16, Table 3), defined as the 95% limits of 
agreement. This noninvasive approach represents a greater degree of accuracy than 
reported accuracy levels of existing invasive anemia screening methods used in low 
resource settings such as the World Health Organization (WHO) color scale60.  
Figure 13: More sophisticate methods of regression seem to have little impact on 
Hgb estimation accuracy. Hgb estimation conducted via (B) neural network 
regression (Error = 1.6g/dL) or (C) random forest ensemble regression (Error = 
1.26g/dL) fail to improve upon Hgb estimation using (A) robust multi linear regression 











Figure 14: The smartphone-based image analysis algorithm accurately measures 
Hgb levels. A) The smartphone image analysis algorithm measures blood Hgb levels to 
within ±1 g/dL of the CBC Hgb level (r = 0.79). The solid line represents the ideal result 
where smartphone Hgb level is equal to the CBC Hgb level whereas the dashed line 
represents the actual data fit. Inset images illustrate example patient-sourced photos that 
were used to calculate Hgb level measurements. B) The Receiver Operating 
Characteristic (ROC) analysis graphically illustrates the algorithm’s diagnostic 
performance against a random chance diagnosis (red line), with an area under the curve 
of 0.5, and a perfect diagnostic (green lines), with an area under the curve of 1. In the 
case of this noninvasive smartphone app Hgb measurement system (black line), the area 
under the curve of 0.87 suggests viable diagnostic performance of this algorithm. When 
using the WHO Hgb level cutoff of < 12.5 g/dL, the sensitivity of the test is 94% (95% 
CI, 89% – 100%), n = 100 patients. C) Bland-Altman analysis reveals minimal 
experimental bias with zero average error, indicating that Hgb measurement is not biased 
in any direction. The dashed line represents the relationship between the residual and the 
average of Hgb level measurements obtained from the CBC and the algorithm (r = 0.22). 
The solid red lines represent 95% limits of agreement (2.6 g/dL). n = 100 
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Table 3: Diagnosis profile of clinical assessment subjects. This study enrolled 337 
individuals with a wide variety of diagnoses.  Study subjects enrolled consisted of 162 
patients with Sickle Cell disease (e.g. type SS, SC, Beta+, Beta 0), 34 patients various 
other anemias (e.g. Beta Thalassemia major and minor, Microcytic, macrocytic, 
normocytic, aplastic, iron deficient, and general anemia), 54 instances of several 
malignancies (e.g. Leukemia, Lymphoma, Sarcoma, Neuroblastoma, Germ Cell Tumor), 
as well as 15 patients suffering from various other blood conditions (e.g. Deep Vein 
Thrombosis, hyperbilirubinemia, Hypogammaglobulinemia, idiopathic thrombocytopenic 
purpura, Purpura fulminans, Pulmonary embolism, Neutropenia, Spherocytosis, 
Thrombocytopenia, Von Willebrand disease). Additionally, 72 healthy control subjects 
were enrolled in the study to ensure that a wide range of Hgb levels were represented. 
Disorder Number of Patients  
 
Hematologic Diseases 
Sickle cell disease 
  Hgb SS 
  Hgb SC 
  Hgb Sβ+ 
  Hgb Sβ0 
Beta thalassemia 
  Major 
  Minor 
Thrombocytopenia 
Aplastic anemia 






Diamond blackfan anemia 








Paroxysmal nocturnal Hgburia (PNH) 
Purpura fulminans 
Spherocytosis 

































Table 3 continued… 
 
Oncologic Diseases 
Acute lymphoblastic leukemia 
Hodgkin’s lymphoma 
Acute myeloid leukemia  
Diffuse large B cell lymphoma 
Neuroblastoma 
Osteosarcoma 
Anaplastic ALK-positive large cell 
lymphoma 
Burkitt’s lymphoma 
Chronic myeloid leukemia 
Ewing’s sarcoma 
Extragonadal germ cell tumor of 
mediastinum 




Sacrococcygeal germ cell tumor 
Spindle cell sarcoma 
Synovial cell sarcoma 





































 Moreover, receiver operating characteristic analysis revealed that this test 
Figure 15: STARD diagram for the general population study when defining a 
positive test for anemia as < 11.0 g/dL 
Figure 16: Diagnosis profile of Hgb measurement subjects. Subjects with hemolytic 
anemia, healthy controls, cancer, other anemia (e.g. aplastic anemia), as well as various 
other blood disorders (e.g. such as thrombocytopenia, deep vein thrombosis, and 
hemophilia) participated in the study. These data represent the diagnosis profiles of the 
subjects shown in Fig. 2. n = 100. 
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achieves a strong diagnostic performance with an area under the curve of 0.87 (Figure 
14B) and highlights the accuracy of this technology throughout the entire range of tested 
Hgb levels. Additionally, there was minimal correlation between patient Hgb levels and 
smartphone-measured residual (r = 0.23), indicating that the algorithm performance 
remained consistent throughout range of tested Hgb levels (Figure 14C). Notably, when 
using a cutoff of <11.0 g/dL to define anemia, a well-established Hgb level threshold 
(Figure 14B, Figure 15),16 the sensitivity and specificity of the system to detect anemia 
was 90% (95% CI, 82% – 98%) and 82% (95% CI, 71% – 93%), respectively. Using the 
WHO Hgb level cutoff for anemia of 12.5 g/dL, the sensitivity of the test improves to 
94% (95% CI, 89% – 100%), indicating the potential for this test to serve as a 
noninvasive screening tool for anemia (Figure 17)98. 
Figure 17: STARD diagram for the general population study when defining a 
positive test for anemia as < 12.5 g/dL 
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Figure 18: Adding a personalized calibration step to generate a patient-specific 
algorithm further improves the accuracy of Hgb levels measurement and is ideal for 
chronic anemia patients. A) Healthy and chronically transfused anemic patients were 
monitored over four weeks (i.e. over the course of a therapeutic blood transfusion cycle). 
CBC Hgb levels (white text) were used in conjunction with the images to generate a 
personalized algorithm for each individual. B) The patient-specific algorithms were used 
to measure Hgb levels over a subsequent blood transfusion cycle. This patient-specific 
calibration improved the average error of Hgb level measurements to within 0.35 g/dL of 
the CBC Hgb level. Bland-Altman analysis shows negligible experimental bias in the data. 
The zero average error (solid black line) indicates the Hgb measurement of the 
smartphone app is not biased towards any direction. The dashed line represents the 
correlation (r = 0.02) between the residual error and the average of Hgb level 
measurements obtained from the CBC and the algorithm. The solid red lines represent 
95% limits of agreement (0.9 g/dL). n = 4 patients, 4 measurements per patient. 
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4.3.9 Personalized Hgb Level Measurements Using the Smartphone Image-based 
Algorithm 
Furthermore, the smartphone-based algorithm was calibrated for each subject (4 
subjects total) over the course of 4 weeks and achieved personalized and accurate Hgb 
level measurements, enabling long-term serial monitoring of Hgb levels (Fig. 4A, Figure 
18, Figure 19). Overall, when used in this manner, this system achieved a level of 
Figure 19: Patient-specific Hgb level measurements are in agreement with CBC 
measurements in the study population throughout a physiologic range of Hgb levels. 
This patient-specific calibration improved the accuracy of Hgb level measurements to 
within 0.35 g/dL of the CBC Hgb level (r = 0.95). The solid line represents the ideal 
result where smartphone Hgb level is equal to the CBC Hgb level. The dashed line 
represents the actual data fit.  n = 4 patients, 4 measurements per patient. 
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accuracy of ± 0.90 g/dL with a bias of 0.0 g/dL compared to CBC Hgb levels (Figure 20), 
again, defined by the 95% limits of agreement (i.e. the Hgb level difference from the gold 
standard that 95% of smartphone measurements will fall between), representing an 
improvement on the reported accuracy of current invasive, point-of-care Hgb tests, such 
as Hemocue7, and clinically-used noninvasive methods such as the Masimo Radical 792.  
Additionally, the smartphone Hgb level measurement residual did not correlate 
with the average between each patient’s CBC Hgb level and smartphone Hgb level with 
(r = 0.02), indicating that residuals were not biased for any specific range of Hgb levels 
Figure 20: STARD Diagram for the personalized calibration study when defining 
a positive test for anemia as < 11.0 g/dL 
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(i.e. algorithm performance remained fairly constant throughout the entire physiologic 
range of tested Hgb levels). Furthermore, this degree of accuracy falls below a clinically 
significant threshold of ±1 g/dL,60,99,100 suggesting that this system can potentially be 
considered interchangeable with the CBC Hgb level given further study101. Furthermore, 
88% of measurements fall within Clinical Laboratory Improvement Amendment (CLIA) 
allowable total error of ±7%102, indicating that upon further refinement and completion of 
additional testing, this technology may potentially be viable for at-home and clinical use.  
4.4 Conclusions and alternative approaches 
There are possible potential sources of error introduced by the design of this 
clinical study. Given the medical histories of the patients visiting the 
hematology/oncology clinic, many of the subjects in the clinical study had low blood Hgb 
levels. If the majority of patients used to train the algorithm had low blood Hgb levels, 
this could potentially cause the algorithm to artificially lower blood Hgb estimates of 
future healthy patients. Also, due to regional demographics, the majority of patients 
enrolled in the study was African-American and possessed relatively dark skin tones. 
Additionally, the majority of these patients with dark skin tones were suffering from 
diseases whose symptoms include low blood Hgb levels. Since these patients were used 
to “train” the algorithm, it is possible that future patients with dark skin tones will have 
artificially low measured Hgb levels. Finally, this experimental design relies on the 
smartphone’s ability to normalize for the different imaging conditions mentioned 
previously (e.g. automatic white balancing, auto-exposure, auto-focus), rather than using 
a color normalization feature located within the image (e.g. a color/whiteness standard). 
However, these automatic normalization functions are not perfect, which could 
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potentially lead to small variations in fingernail color and skin tone unrelated to the blood 
Hgb concentration. Additionally, some of the participants in the clinical study were on 
therapeutic drugs that have been shown to affect fingernail color. While subjects were 
typically excluded if they had nailbed discolorations or abnormalities, it is possible that a 
subject was included that had a very subtle discoloration due to medications.  
A possible source of the experimental bias I have identified is the distribution of 
Hgb levels in the study population. I have attempted to engineer the training data set such 
that Hgb levels in the training population are uniformly distributed, in order to ensure the 
prediction algorithm is not biased towards any Hgb level. However, because so many 
subjects were used in the training population, the left-over testing population still had a 
Hgb level distribution heavily influenced by anemic Hgb levels. In order to ensure that 
both the training and testing subject groups have uniform Hgb distributions, as well as 
enough subjects to prove the algorithms utility as a Hgb screening tool, I will begin 
seeking out healthy subjects with Hgb levels in the normal range to take part in future 
iterations of this study. The previously mentioned techniques will be used to generate 
new prediction algorithms based on the new study populations. It is possible that this 
method of Hgb estimation will not achieve the accuracy necessary to be a clinically 
valuable diagnostic tool. This could occur either due to the inability to account for 
experimental bias or that pallor variability between patients is simply too great for this 
method of Hgb estimation to account for. If this is the case, I will investigate more 
sophisticated modeling methods to generate the prediction algorithm in greater depth. 
One such modeling technique involves the use of machine learning and neural networks, 
as discussed previously, which takes advantage of the ability of computers to iteratively 
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learn more complicated models and extract features and parameters within images of 
fingernail beds that are not readily apparent to the human eye103. While these techniques 
did not improve Hgb measurement accuracy when applied to the study population 
presented in this chapter, it is possible that the more sophisticated, machine learning-
based Hgb estimation methods will improve when trained with a much larger patient 
sample size encompassing a uniformly distributed Hgb level distribution. These 
techniques have shown great promise in diagnosing a variety of medical problems from 
diabetic neuropathy to skin cancer77,78. By inserting a regression layer on top of the deep 
neural network, covariates (such as age, anemia etiology, camera type, etc.) can easily be 
factored in to the regression to optimize the algorithm. Although it is traditionally 
expected that thousands of patients are needed for deep learning to bear fruit, researchers 
have seen improvements over state of the art algorithm just using hundreds of patients104. 
Therefore, the use of more subjects representing numerous etiologies, as well as healthy 
controls (50% male/50% female) will ensure the scientific rigor of this approach. 
Moreover, multiple recordings per patient, which has not been implemented in the current 
testing protocol, have the capability to enhance such algorithms, while cross validation 
ensures that I will not over-train on a given population. This will be attempted once 
additional subjects with healthy Hgb levels are enrolled in the study and the study 
population contains a more uniformly-distributed Hgb level distribution. I will utilize the 
vast amount of computing power at my disposal at the Georgia Institute of Technology 
and Emory University to develop these complicated models to solve the regression 
problem this project presents. Overall, these data highlight the ability of clinical pallor to 
be correlated quantitatively with blood Hgb levels in subject’s who are both healthy and 
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suffer from a wide range of disorders. These results indicate that this method may be used 
to noninvasively measure Hgb and diagnose anemia and that future studies may improve 




CHAPTER 5. PERFORM USABILITY TESTING AND 
INCORPORATE THIS ALGORITHM INTO A 
TRANSLATIONAL, EASY TO USE, AND INEXPENSIVE 
SMARTPHONE APPLICATION. 
5.1 Introduction 
In order to achieve its potential as a noninvasive diagnostic tool capable of 
remotely screening for anemia, this image analysis algorithm must be incorporated into a 
medical device that patients and healthcare providers can use. Smartphone ownership is 
increasing worldwide, and many medical devices have been designed that are 
incorporated into smartphones, or interface with mobile technology. As this image 
analysis algorithm for measuring Hgb levels utilizes only smartphone images of a 
subject’s fingernail beds without the use of any external equipment, incorporation into a 
mobile app was a natural fit to allow for noninvasive self-diagnosis of anemia. The 
ability to function using a smartphone alone represents a substantial benefit to a user as 
they already have the medical device (the smartphone) in many cases and must only 
download an app to unlock this additional capability of their smartphone. 
In this chapter, I discuss the integration of this image analysis algorithm into a 
fully functioning standalone smartphone app as well as the diagnostic accuracy of this 
app compared to the accuracy of a physical examination by a physician. I also discuss the 
user interface considerations that went into app development, as well as the incorporation 
of the app in multiple operating systems. I conclude with a discussion of the challenges 
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that come along with using multiple smartphone models that contain different camera 
hardware and the challenges of accounting for this hardware variability. 
5.2 Materials and Methods 
5.2.1 App Development 
5.2.1.1 Software 
The Hgb level measurement algorithm was incorporated into mobile apps. The 
open source integrated development environment (IDE) Android Studio (Google, 
Mountain View, CA) was used to develop a beta version of the Hgb measurement app in 
the Android operating system. The proprietary IDE Xcode (Apple, Cupertino, CA) was 
used to develop a beta version of the app in the iOS operating system. 
5.2.1.2 Beta Testing 
Design consideration that ultimately led to the process flow described below were 
determined by assessing the functional and technical requirements of a Hgb measurement 
app, as well as convenience and usability requirements determined via beta testing. Beta 
testing was conducted on a group of individuals who were comfortable with use of a 
smartphone but had no knowledge of application or software development. Users were 
given basic instruction on how to use the app and asked to provide feedback regarding 
usability of the app. This process was used to generate iterative improvements to the 
process flow of the app. The primary outcomes of this preliminary beta testfocused on 
how information was displayed and how instructions were presented to the user. In 
response to beta testing feedback, each set of instructions presented in the app process 
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flow is now presented to the user in a large, easy-to-see text box on the smartphone 
display. In some cases, images are included with these instructions that visually 
demonstrate the actions a user must take. For instance, the hand position that was used in 
the clinical study is demonstrated to the user to facilitate mimicking of the correct hand 
position to obtain accurate Hgb measurement.  
5.2.1.3 Process Flow 
The process flow for the apps that I have developed on both iOS and Android 
platforms is as follows and can be summarized by Figure 21:  
1. The user is prompted to enter a patient ID, which allows patient data to be 
stored and collected for future analysis based on a deidentified number. 
This number prevents the subject’s personal information such as name, 
date-of-birth, sex, etc. to be linked to data collection in any way. 
2. The user is prompted to take an image with the camera flash on. The 
smartphone’s default camera app is opened which allows the user to take 
an image, view the image, and choose whether or not to use said image. 
The image is then transferred back to the app where the user yet again has 
the option to choose retake the image. 
3. The user is then prompted to manually choose ROI within the image. The 
user must then tap the image on each ROI (i.e. the patients 4 fingernails in 
the image excluding the thumb). This will trigger green boxes to be drawn 
around each region of interest.  
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4. The user will then be prompted to check and make sure the image looks is 
adequate for Hgb measurement. The user must check to make sure that 
fingernails are present in the image, fingernail beds are clearly visible (e.g. 
no glare/flash reflection, imaging artifacts, etc.), and the boxes are 
completely contained within the fingernail beds. If the image is 
determined to be unsatisfactory, the user has the option to retake the image 
or to redraw the boxes and reselect the regions of interest corresponding to 
the fingernail beds. 
5. The user is prompted to measure the Hgb level of the fingernail image. 
This data can be recorded by the user. 
After conducting the Hgb measurement using the app, the app stores the data for 
future analysis. The color data, image metadata, and the Hgb result are stored in a text 
file on the internal storage of the smartphone. The image taken by the user is also saved 
on the internal storage of the smartphone for future reference. 
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Figure 21: Smartphone app for diagnosing anemia process flow 
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5.2.2 Skin Tone and Lighting Condition Analysis 
Automated analysis of skin tone was employed to measure the effect that a 
subject’s skin tone had in the algorithm’s ability to accurately measure Hgb levels. The 
Figure 22: Example implementation of the smartphone image analysis system into a 
smartphone app enables non-invasive, patient-based measurement of blood Hgb  
levels via patient-sourced photos using only native hardware of the smartphone 
itself. A-C) proposed implementation of this system integrated into a smartphone app. A 
i-ii) As a patient obtains a smartphone photo of his/her fingernail beds, and without the 
need for any blood sampling or additional smartphone attachments or external calibration 
tools, B) the smartphone image analysis app quantitatively measures blood Hgb levels. C 
i) As smartphone images with fingernail irregularities such as camera flash reflections or 
leukonychia may affect Hgb level measurements, quality control measures of the Hgb 
measurement app detects and omits those irregularities to preserve measurement integrity 
and accuracy. C ii) To that end, the app randomly selects regions of interest from within 
the fingernail image, C iii) and any color values that fall outside of expected color ranges 
are excluded from Hgb measurement. In this example, when the quality control system 
was implemented to exclude the fingernail bed irregularities, Hgb level was measured to 
be 14.7 g/dL, comparable to the patient’s CBC Hgb level of 15.3 g/dL. When the quality 
control was not implemented, Hgb level was measured at 12.8 g/dL. The quality control 
algorithm therefore resulted in a 76% reduction in error. Note that as the smartphone 
image-based algorithm is device-agnostic, the analysis of the smartphone images could 
also be transmitted to another device (e.g. laptop, cloud-based server) for remote analysis. 
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CIELAB color space was designed as a device-independent color space capable of 
approximating human vision94. Much like the human brain, this color space distinguishes 
between light and dark (“L” value), between red and green (“A” value), and between blue 
and yellow (“B” value). A patch of skin on the middle finger was selected from each 
image, and the RGB color values in this region were transformed into the CIELAB 
colorspace. The lightness, or “L*”, value most accurately represents human perception of 
skin color and serves as a n ideal variable linearly modeling skin tones in a population on 
a scale of dark skin to light skin95. The average “L*” value was found within the skin 
patch via a custom MATLAB script and compared with the residual for each image to 
establish the effect that skin tone (dark vs light) has on Hgb measurement accuracy (Fig. 
S2B). Furthermore, the impact of background lighting conditions was analyzed by 
recording background brightness via a digital light meter. Impact of background 
brightness on Hgb measurement was determined by comparison of background 
brightness with residuals.  
5.2.3 Phone parameter analysis 
A single subject’s fingernail beds were imaged using multiple makes and models 
of smartphones (Apple, Cupertino, CA; Motorola, Schaumburg, IL). Each image was 
taken in the same location in rapid succession (~15 sec between images) in order to 
minimize fluctuations due to Hgb variation over time and background lighting condition. 




5.2.4 Quality Control 
5.2.4.1 Fingernail irregularity exclusion 
Preliminary experiments were completed to develop image analysis algorithms 
capable of performing quality control on the images, allowing me to minimize the impact 
of fingernail or image irregularities. A sample image of an individual with leukonychia 
(also known as white nails) was taken, producing a camera flash reflection on some nails. 
ROIs were chosen to contain these imaging and fingernail irregularities, and software 
was written in MATLAB to exclude them. Color values in the ROI were excluded if they 
fell outside of the expected color range of fingernail beds. The expected color range was 
calculated as the standard deviation of the average pixel intensity color values for the 
study population.  
5.2.4.2 Detecting Presence of fingernails  
In addition to excluding irregularities, I was able to determine the presence of 
fingernails using the Vision application programming interface (API) (Google, Mountain 
View, CA). A script was written in Python using the IDLE IDE that sends images to the 
Google platform, makes requests of the cloud service, and receives and interprets results 
from the server. Initially, images of fingernail beds are sent to the server with a request. 
The request asks the server via the Vision API to characterize or label the images that it 
receives. Machine learning algorithms are used in conjunction with Google’s vast 
repository of images to label the image based on the content of that image. The custom 
Python script receives, interprets, and then characterizes the result. The response from the 
server is typically a series of 5 labels, along with corresponding data regarding the degree 
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of confidence in that label being correct. This quality control looks for the label “finger” 
or “fingernail” and records its confidence, allowing me to determine whether or not a 
user has indeed taken an image of a fingernail bed. Incorrect labels and responses are also 
categorized.  
5.2.5 Blood flow interference 
Table 4: Hgb level measurement experiences little variation when subjects are 
subjected to increased heart rate or changes in hand temperature. When heart rate 
increased due to moderate and heavy exercise, Hgb level measurement increased by 0.19 
g/dL and 0.78 g/dL relative to resting heart rate (75BPM) Hgb level measurement, 
respectively. When hand temperatures corresponding to exposure to ambient 
temperatures of 4oC and 39oC, Hgb level measurement increased by 0.62 g/dL and 
0.52g/dL, respectively, relative to room temperature (24oC) Hgb level measurement. n = 
4 per case (resting heart rate, room temperature, etc.).  In each case, this change is 
clinically insignificant. Throughout the course of this entire study, regardless of the 
conditions, the mean |error| = 1.08 g/dL, n = 24 measurements, which is nearly the same 
as the mean |error| of the large scale clinical study (± 1.04 g/dL). 
 Mean Heart Rate  Ambient Temperature 





 0.19 g/dL  0.78 g/dL  0.62 g/dL  0.52 g/dL 
The impacts of increases in heart rate as well as fluctuations in hand temperature 
were examined, as  both conditions alter blood flow and fluctuations in blood flow to the 
fingernail beds may potentially affect Hgb measurement105,106. Even when heart rate 
increased significantly due to moderate or heavy exercise (100 BPM and 149 BPM, 
respectively) Hgb measurements only slightly increased by 0.19 g/dL and 0.78 g/dL 
when compared to Hgb measurement at resting heart rate (75BPM). When hand 
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temperature fluctuated between -4C or +3C of room temperature levels, corresponding to 
exposure to ambient temperatures of 4oC and 39oC, Hgb measurements increased by 0.62 
g/dL and 0.52 g/dL, respectively, relative to Hgb measurement at room temperature 
(24oC). However, in either case, the increase was not clinically significant (Table 4).  
5.2.6 Heart Rate interference 
Additional subjects’ (n = 4) resting heart rates were measured and their fingernail 
beds were imaged at resting heart rate. Subjects were then instructed to conduct mild 
exercise (walking) and, subsequently, heavy exercise (jumping jacks) for one minute in 
order to increase and record heart rate. Fingernail beds were imaged after mild and heavy 
exercise. A blood draw was conducted and Hgb levels were determined with a CBC.  
Images from each activity state were used to measure Hgb via the image analysis 
algorithm and to measure the impact that heart rate has on smartphone Hgb measurement.  
5.2.7 Skin Temperature Interference 
Additional subjects’ (n = 4) hands were dipped in cooled or heated water until a 
temperature change of -4oC or +3oC was recorded, respectively. Fingernail beds were 
imaged after each condition, as well as prior to temperature change, to establish a 
baseline. A blood draw was conducted, and Hgb levels were determined with a CBC. 
Images from each hand temperature condition were used to measure Hgb via the image 
analysis algorithm and determine the impact that skin temperature has on smartphone 





Ten images were taken of an individual’s fingernails, and Hgb was measured via 
the image analysis algorithm on each image. Repeatability was reported as the standard 
deviation of the measured Hgb levels. 
5.2.9  Camera color calibration 
5.2.9.1 Color calibration scheme 
Camera calibration was used in order to facilitate agreement between the Hgb 
readouts between multiple models of smartphones, as different phones use different 
cameras. Images of the same subject matter (Figure 23) were taken under identical 
conditions and on multiple different models of smartphones including the iPhone 5S, 
iPhone 7 (Apple, Cupertino CA), and Samsung Galaxy S7 (Samsung, Seoul, South 
Korea). The subject matter in these images consisted of a collage of paint swatches (The 
Home Depot, Atlanta GA) arranged in a grid containing different colors spanning the 
entire RGB color space. RGB data was extracted from regions within each of these grids 
on each image from the multiple smartphone models. Since the Hgb measurement 
algorithm was developed using images taken from an iPhone 5S, color data from images 
taken with the other smartphone models was compared to the color data taken from the 
iPhone 5S in order to develop a color transformation that relates RGB information of the 




5.2.9.2 RGB transform 
The RGB transform function was developed by first collecting RGB data from 
each colored region in the color calibration card within images taken on each camera 
type. For each color (R, G, B) linear regression was used with the RGB values from 
iPhone 5S (the original phone the algorithm was developed on) as the independent 
variables and the RGB values from the other phones as the dependent variables (Figure 
24). The equation of the resulting regression lines were used to transform RGB values of 
the images taken on new phones so that they matched the RGB values of the original 
phone. Linear regression and r2 values were calculated with Microsoft Excel (Microsoft, 
Redmond, WA). 
 
Figure 23: Color calibration card design. Images of the above color calibration card 
were taken using multiple smartphone models, and the differences in RGB color data 
from each color region within the image were used to develop an RGB calibration 
transformation for each smartphone model. 
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5.2.10 Physician vs app performance comparison 
Testing was conducted to compare the diagnostic power of physicians against the 
diagnostic power of the hemoglobin measurement app. A panel of 5 trained and board-
certified hematologists from CHOA, Emory University, and Grady Hospital measured 
Hgb levels and their diagnostic accuracy was compared against that of the app. Accuracy 
testing was conducted in two phases: 1) measuring Hgb using images of subjects’ 
fingernails, and 2) using Hgb measurements from in-person physical examinations of 
subjects’ clinical pallor. Diagnostic accuracy for comparison was determined by CBC 
testing. Each subject had a blood venous draw and a CBC was conducted using a clinical 
hematology analyzer (Advia 2120i, Siemens, Berlin, Germany). 
Figure 24: Linear regression was used to correlate RGB values extracted from 
images taken by multiple smartphones to RGB values taken from iPhone 5S images. 
Red (A), Green (B), and Blue (C) pixel intensity values were extracted from each box in 
the color calibration card. Each data point represents the RGB value taken from a single 
square on a given phone. Values derived from the iPhone 5S (the original phone the Hgb 
measurement algorithm was developed on) are plotted on the X-axis and values derived 
from new, prospective phones are plotted on the Y-axis. Linear regressions were 
calculated for each prospective phone against the iPhone 5S and the resulting equation 
displayed relates RGB values from each new phone (iPhone 7 – Top, Galaxy S7 - 
Bottom) to RGB values of the original phone.  
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5.2.10.1 Hemoglobin measurement via physical examination 
These physicians were told to inspect the fingernails of 22 subjects and measure 
their hemoglobin levels. A research associate then used the app to measure these subjects 
Hgb levels. These subjects’ ages ranged from 25 to 62 years old. In order to minimize the 
possibility of other physical factors subconsciously influencing the analysis of the 
physicians, a second study was conducted using image of subjects’ fingernails. 
5.2.10.2 Hemoglobin measurement from images of fingernails 
Images were taken of 50 subjects fingernails from the previously described 
clinical study. These subjects’ ages ranged from 1 to 62 years old. Physicians were 
instructed to analyze each image and measure Hgb levels. For comparison, images were 
loaded into the app, and the Hgb measurement protocol was performed on these images. 
All images and analysis were taken using an iPhone 5S. It is important to note that these 
images were not used in the development of the underlying image analysis algorithm. 
5.2.11 Study Approval 
The study regarding the relation of finger temperature and exercise to 





5.3 Results and Discussion 
5.3.1 Quality control measures eliminate error caused by fingernail irregularities and 
ensure presence of fingernails in each image taken. 
I have implemented quality control measures into the app to enable the app to 
perform better when presented with challenges such as irregular fingernail beds and user 
error. Quality control software has the ability to exclude common fingernail irregularities 
from Hgb calculation. This is done by excluding fingernail regions that are significantly 
lighter or significantly darker than the average fingernail bed. These abnormally light or 
dark regions correspond to nailbed irregularities such as bruising due to injury, 
leukonychia, melanonychia, camera flash and external light reflection, or side effects of 
certain medications (e.g. chemotherapy drug treatments can lead to irregular striping of 
the nailbed107). Preliminary results are promising, indicating that Hgb level measurement 
improves to 14.7 g/dL up from 12.8 g/dL (CBC Hgb = 15.3 g/dL) in a single patient 
when quality control software is used (Figure 22C). I hypothesize that the subject’s 
leukonychia and camera flash reflection off the surface of the fingernail are incorrectly 
being interpreted as clinical pallor by the algorithm, leading to artificially low Hgb level 
measurement. The impact of these irregularities seems to be mitigated by quality control 
software, indicating that quality control is essential to ensuring that true Hgb level 
measurements are obtained. Furthermore, quality control characterization utilizing 
Google’s cloud computing service and Vision API is able to effectively and efficiently 
characterize fingernail images by quickly determining the presence of fingernails in an 
image. For this technology to achieve its full potential, it will need to be implemented 
into a smartphone app that patients can download and use at home, and this home-based 
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use model will likely introduce some user error that was not seen when testing was 
conducted by an expert user of this technology. I pre-emptively addressed the most basic 
usability concern by determining whether a fingernail was present at all within an image. 
Each image taken during the clinical study was process by the Google Vision API via the 
Google cloud service. 332 of 337 images analyzed were characterized as containing a 
“finger” or “fingernail” (Figure 25). Furthermore, approximately 97% of images analyzed 
were characterized as containing these objects with a degree of certainty of greater than 
85%.  If implemented into the app, this result will enable the app to ensure that a user has 
indeed captured an image of their fingernails sufficient to conduct Hgb measurement, 
eliminating a major potential source of user error. This should significantly improve app 
performance when used at home.  
Figure 25: Degree of certainty that a fingernail is present in clinical study 
photos. Each response from Google Vision API containing the word “finger” or 
“fingernail” was recorded. All but 5 clinical study images returned one of these 
words. ~97% of responses were characterized as containing a finger or fingernail 
with a degree of certainty of > 0.85. N = 337 images  
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5.3.2 Images taken of subjects’ fingernail beds are consistent amongst smartphone 
images taken with different makes and models of smartphones when color 
calibration strategies are utilized.  
This algorithm must be easily accessible by the smartphones used to image subjects’ 
fingernails in order to maximize the impact that this image analysis anemia prediction 
algorithm can make. This can best be accomplished in the form of an on-board 
smartphone application. The smartphone market is large and diverse. An application 
relying on data extracted from images taken by a smartphone must be camera-agnostic to 
ensure that the same readings are given regardless of the make or model of the camera 
used to take pictures. Preliminary studies have been conducted to ensure cameras from 
different mobile phones produce similar images of subjects’ fingernails. Images of a 
Figure 26: The image analysis algorithm is camera-agnostic. A) RGB values of both 
fingernails and the skin of within a sample image taken with different models of 
smartphones remain consistent. n = 10 phones. B) There was no statistically significant 
difference between two different smartphone models developed by the same 
manufacturer (P > 0.05). Statistical analysis was performed with a student’s t-test 
assuming unequal variance. n = 3 phones/model. Error bar reported as standard deviation 
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single subject’s fingernail beds were taken under identical imaging conditions using 
multiple smartphone models and the results were compared. Images were taken using 
phones made from different manufactures, including Apple and Motorola, as well as 
different models of phones made by the same manufacturer (i.e. Apple iPhone 4, 5, 5s, 6, 
6s+). I have shown that RGB pixel intensity values of the subject’s fingernail beds and a 
control patch of skin are remarkably similar between images taken with different 
smartphones (Figure 26A). Additionally, I show no statistically significant difference (p 
> 0.05) between pixel intensity values of images of fingernail beds taken by two different 
models of Apple iPhones (Figure 26B), with  the exception of the r channel pixel 
intensity value of the fingernail bed (p = 0.03). However, this difference is very small (~4 
A.U.), contributing to a difference in Hgb level estimation of approximately 0.2g/dL).   
However, further studies show that this pixel intensity agreement not the case 
Figure 27: Color calibration facilitates agreement between alternate smartphone 
models. When the color calibration protocol is used, alternate models of smartphones 
(iPhone 7 and Samsung Galaxy S7) display similar results. The app was tested on the 
same group of subjects in each case. An offset from the ideal result is present (N = 11).  
 85 
with newer models of Samsung and Apple phones. Thus, color calibration was necessary 
to facilitate pixel intensity agreement between images taken on the different models of 
smartphones. Taking images of color arrays with the different smartphone models 
allowed me to develop a pixel intensity value transformation to relate the data from each 
smartphone to ensure Hgb measurement accuracy (Figure 23, Figure 24). Implementation 
of this transformation facilitates agreement between the alternate smartphone models 
(iPhone 7 and Samsung Galaxy S7), however, some experimental bias has been 
introduced that causes a slight offset from the iPhone 5S Hgb measurement baseline that 
must be corrected (Figure 27). 
5.3.3 Smartphone Image-based Algorithm Performance to Potential Sources of 
Interference and Variability 
Use of fingernail beds as the imaging area is ideal due to the fact that fingernail 
beds contain minimal amounts of melanin compared to other parts of the skin67,68, 
theoretically enabling this technique to be insensitive to subject skin tone. Preliminary 
results presented earlier seem to support this hypothesis (Figure 12). To further address 
this experimentally using the most accurate Hgb measurement algorithm, images were 
converted into the CIELAB color space, a commonly used color quantification system 
that quantifies color as perceived by the human eye67. In particular, the L* value in this 
color space has been shown to serve as a linear indicator of skin tone67. The relationship 
between the subjects’ skin tones and Hgb measurement residuals was determined by 
measuring the L* value of a patch of skin adjacent to the fingernail. L* did not correlate 
(r = 0.17) with Hgb measurement residual, indicating that subject skin tone has little 
impact on the ability of this system to measure Hgb levels (Figure 28A).  
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For accessibility in dynamic clinical settings, the smartphone Hgb level 
estimation technology must function under a wide variety of background lighting 
conditions. To that end, using luminous flux readings on a digital light meter, no 
correlation (r = 0.004) was found between room brightness and Hgb measurement 
residual, indicating that this method can be used in a wide variety of settings and lighting 
conditions (Figure 28B). Use of the camera flash resulted in the most accurate Hgb level 
measurement, likely due to the normalization of background lighting conditions provided 
by the camera flash (Figure 29). Furthermore, ensuring that the technology is agnostic to 
the smartphone make and model, RGB pixel intensity values of the subject’s fingernail 
beds and a control patch of skin were found to be similar between images taken with 
smartphones made from different manufacturers and models (Figure 26A). Additionally, 
  
 
     
       
 
Figure 28: Background lighting and subject skin tone have minimal effect on Hgb 
measurement accuracy. Plotting measurement error against (A) skin tone and (B) 
background lighting reveals low and negligible correlation (r = 0.17 and r = 0.004 
respectively) in either case. Dashed lines indicate linear fit between the measurement 
error and the tested parameter (skin tone and background lighting respectively). Inset 
images highlight a representative range of measured background skin tones and lighting 
conditions. n = 100 patients. 
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no statistically significant difference existed between pixel intensity values of fingernail 
bed images obtained by two different smartphone (Figure 26B). Finally, the precision of 
Hgb level measurements using this technology was found to be ±0.17 g/dL when tested 
on multiple images of the same individual’s fingernails.  
5.3.4 Color calibration facilitates agreement in Hgb measurement between different 
smartphone models  
While preliminary data showed that there is little variability between smartphone 
images, the limited variability is sufficient to cause disagreement in Hgb measurement 
between different smartphone models when the image analysis algorithm is integrated 
into smartphone apps. In order to resolve this disagreement, I developed a color 
calibration protocol. In this protocol, images are taken of multiple standardized colors 
and the RGB color data is compared between the different phones. Using the iPhone 5S 
as the standard and independent variable in linear regression analysis, an equation is 
developed that can be used to transform RGB values of other smartphone models to fit 
the Hgb measurement model designed using iPhone 5S images (Figure 27). This protocol 
can be adapted to conduct color calibration on any future smartphone models that become 
available and in which compatibility with this app is desired. 
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5.3.5 The app outperforms trained hematologists’s ability to measure Hgb levels via 
physical examination. 
Hematologists were challenged to measure Hgb levels in patients via physical 
examination of the fingernails as well as inspection of images of fingernails. When 
Figure 29: Camera flash improves performance of the Hgb measurement algorithm. 
Use of the camera flash (A-B) leads to a decrease in the Hgb measurement error, as well 
as an increase in the correlation between the smartphone and CBC measurements, 
compared to when no camera flash is used (Flash on: r = 0.23 Flash off: r = 0.35) (C-D). 
Bland-Altman analysis shows a slight decrease in the correlation between the residual 
and the average Hgb level between the two tests when the camera flash is used. This 
indicates the presence of some experimental bias that is mitigated by use of the camera 
flash.  n = 100 
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physical exams were conducted, there was no difference between the diagnostic 
performance of trained haematologists (1.76 g/dL average error) vs the app (1.83 g/dL 
average error) in this preliminary study. I hypothesize that this could have been the case 
due to the Hgb distribution of the study subject pool. In the subject pool for physical 
examinations (n = 22), Hgb levels ranged from 10.7 g/dL to 16.9 g/dL. Thus, none of the 
Figure 30: Smartphone app outperforms hematologist estimations when diagnosing 
Hgb using images of fingernails. A) Pooled results of 5 trained hematologist’s Hgb 
measurements after inspection of fingernail images. Measurements were accurate to 
within ± 4.5 g/dL (95% CI, r2 = 0.13, n = 50 subjects, N = 5 hematologists). B) Results of 
Hgb measurement via the app. Measurements were accurate to within ± 1.0 g/dL (95% 
CI, r2 = 0.91, n = 50 subjects). C, D) ROC curves of the haematologist response (AUC = 
0.63) are much closer than the app responses (AUC = 0.94) to the random chance line, 
indicating that the App has a greater diagnostic accuracy than trained haematologists. 
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subjects were anemic, leading to the app and physicians to measure similar Hgb levels. 
Furthermore, it is likely that the physicians displayed some bias when measuring Hgb, as 
they had no reason to expect that these subjects were anemic (the subjects were identified 
and consented from a research lab at the Georgia Institute of Technology rather than a 
clinical setting. This could have potentially led to artificially high Hgb results.  
 In order to account for physician bias and include a wider range of Hgb levels to 
more accurately reflect the general population who could potentially use this app, images 
of patients were used for comparison of the diagnostic capabilities of physicians and the 
app. When looking at images of fingernail beds, the hematologists measured Hgb levels 
to within ± 4.5 g/dL (95% CI, r2 = 0.13, n = 50, Figure 30A). When the app was used to 
measure Hgb on the same images, the app was able to measure Hgb to within ± 1 g/dL 
(95% CI, r2 = 0.91, n = 50, Figure 30B). This represents a significant improvement and 
proves that the image analysis algorithm translates well upon integration into a 
smartphone app. In fact, there is an increase in diagnostic accuracy when the app is used, 
likely due to the quality control software that has been implemented.  
5.4 Conclusions and Future Approaches 
It is possible that this Hgb estimation technique will not work under extreme 
lighting conditions. It is necessary to conduct experiments to determine the lighting 
condition boundaries under which the algorithm successfully determines Hgb levels. This 
will be done by measuring the error in Hgb level estimation of the same subject in 
various lighting conditions exceeding the conditions typically found in clinical settings. 
These settings represent potential field use of this technology. This is an important 
 91 
experiment to conduct, as the primary value proposition of this technology to the user is 
based on the ability to conduct Hgb testing away from clinical settings.  
In order to develop a truly POC diagnostic tool, the Hgb estimation algorithm 
must be incorporated into a mobile platform and used by individuals with, or at risk for, 
anemia. In order to ensure that this diverse user base can accurately measure their Hgb 
levels, a “quality control” system must be in place to ensure that the images being taken 
by these users are of sufficient quality to generate accurate Hgb level results. While 
preliminary quality control systems have already been developed, further algorithms will 
be develop which account for other common irregularities in images of fingernails will be 
developed. In addition to the abnormalities studied, image irregularities that could lead to 
inaccurate Hgb level estimation include presence of abnormal fingernail bed 
pigmentation, abnormal imaging brightness, and lack of image focus. These algorithms 
will serve as an extension of the preliminary quality control algorithms already 
developed. Convolution of fingernail bed images with edge detection kernels108 will be 
used to detect edges within the fingernail beds corresponding to abrupt color changes 
caused by abnormal fingernail bed pigmentation for each finger. Data from fingernail 
beds with irregular pigments and irregularities will be removed from consideration during 
Hgb level measurement. An acceptable range of background brightness will be 
established using images taken as part of the clinical study which have been shown to 
allow for accurate Hgb estimation. The quality control algorithm will simply compare the 
background brightness to the reference standard to determine whether or not to reject the 
image. The quality control algorithm will reject out-of-focus images as well. 
Determination of the “sharpness” of image focus can be determined in conjunction with 
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the edge detection function previously described. The intensity of edges will determine 
how sharp, or in focus, they are. A sharpness of edges metric will be determined using 
images that have been shown to yield an accurate Hgb level estimation. This metric will 
be used to determine rejection criteria for image focus. This “quality control” algorithm 
will be used to reject images that could potentially yield inaccurate Hgb estimation 
results and will prompt the user to take higher quality images. 
As I have presented in this chapter, there are significant differences in how 
images are interpreted across different models and manufacturers of smartphone. The 
color correction protocol must serve as a blueprint for enabling the app to function 
properly on smartphones that have not currently been tested. Further testing must be 
conducted to optimize this protocol, as there exists some disagreement in Hgb levels 
measured on more advanced smartphone models compared to the model used to 
originally develop the Hgb measurement algorithm. Furthermore it is possible that 
requiring subjects to manually select regions of interest within images of their fingernail 
beds will prove difficult, causing inaccurate Hgb estimation. If this is the case, it may be 
necessary to build in an image analysis feature that extracts regions of interest 
automatically, which is an option that I have explored via utilization of convolutional 
neural networks that have been used in computer vision. Overall, I am able to report 
successful preliminary implementation of this image analysis algorithm into multiple 
mobile platforms across different smartphone manufacturers. As this technology in its 
current form is capable of outperforming trained hematologists in anemia diagnosis from 
physical examinations of fingernail bed images, this app represents a major step in the 
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development of a truly translational, noninvasive, convenient, and inexpensive diagnostic 
tool for anemia.  
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CHAPTER 6. CONCLUDING REMARKS AND FUTURE 
DIRECTIONS 
Given the performance of this technology in the general population, this 
completely noninvasive technology that requires only photos obtained from smartphones 
has significant implications as a screening tool in the general population, as anemia is 
prevalent worldwide, afflicting nearly two billion people, especially young children, the 
elderly, and pregnant women. The ability to inexpensively diagnose anemia with high 
sensitivity, completely noninvasively, and without the need for any external smartphone 
attachments or calibration equipment represents a significant improvement over current 
POC anemia screening. Optimizing sensitivity is of paramount importance for a 
screening tool, due to the ability to correctly identify a high percentage of anemia cases 
even if this negatively impacts specificity. In its current form, this technology requires 
the user to simply obtain a fingernail image, which can then be analyzed with an on-
board smartphone app that comprises a novel image analysis algorithm to output the Hgb 
level measurement or be transmitted remotely to another device (e.g. laptop, desktop 
computer, or cloud-based server with my algorithm embedded into their systems) for 
remote analysis, the results of which can be immediately transmitted back to the user. 
After identifying subjects that may possibly be anemic, either type of system can 
recommend confirmatory Hgb level testing with a CBC, allowing any false positives to 
avoid unnecessary treatment. Given the ever-increasing rate and near ubiquity of 
smartphone ownership worldwide9, this noninvasive, inexpensive, patient-operated Hgb 
measurement algorithm allows those at risk of anemia to monitor their conditions using 
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only the native hardware included with their own smartphone. This is particularly 
pertinent in low resource settings where, contradictory to the relative lack of medical 
infrastructure, mobile phone networks are quite extensive and have “leapfrogged” 
landlines109.  
Additionally, this system has the potential to fundamentally alter the management 
of patients with chronic anemia. During the course of several weeks, a patient may take 
images of their fingernail beds and enter their CBC-measured Hgb levels that were 
obtained as part of their regular outpatient clinical care. Results suggest that these images 
and Hgb levels may be used to “teach” the smartphone phone to develop a “calibration” 
personalized and tailored to each individual patient. In times of clinical stress, these 
patients, such as those with genetic causes of anemia or with cancer and are undergoing 
chemotherapy, may experience rapid, life-threatening, precipitous drops in Hgb and 
require constant monitoring to determine their need for transfusions. Using this 
technology, patients could potentially self-monitor their anemia from the comfort of their 
own home, rather than through inconvenient and recurring clinic visits. In addition, some 
patients with chronic anemia due to a genetic etiology require chronic transfusions to 
survive. These scheduled transfusions are currently administered at convenient and 
regular intervals, and not based on clinical need110. Hence, a patient may be transfused 
too early, exposing them to unnecessary transfusion-related effects (i.e. iron overload, 
risk of infection), while patients transfused too late may require urgent hospitalization if 
they develop symptomatic anemia or their Hgb levels decrease to a dangerous level. By 
enabling continuous and simple monitoring, this technique may empower patients and 
lead to better allocation of blood bank resources. Moreover, further data collection will 
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increase the size of the patient image pool, facilitating the incorporation of deep machine 
learning “Big Data” techniques to further refine the Hgb measurement algorithm111.   
Overall, this CBC-validated, smartphone image-based Hgb measurement 
technology has the potential to dramatically improve upon the accuracy, cost, and 
convenience of current Hgb measurement devices while also eliminating the need for 
anything other than a smartphone, representing a significant improvement over other 
POC Hgb measurement technologies5,6,24,25,57,112,113. With this smartphone image-based 
Hgb measurement system, any person – healthy or ill - in any location, at any time, now 
has access to an important health metric and may seek care accordingly. Moreover, 
healthcare officials in low resource settings may use this technology to  efficiently and 
effectively allocate limited healthcare resources (e.g. transfusions, high-risk obstetrical 
services) and medications (e.g. nutritional supplementation such as iron, folate, or 
vitamin B12)114 for the patients with the most severe anemia. This completely 
noninvasive, algorithm-based approach represents a paradigm shift in the way anemia can 
be screened, diagnosed, and monitored globally. As the system requires no reagents or 
equipment, the healthcare cost savings could also be significant.  
Going forward, the potential for user error as well as inter/intra-smartphone 
variability leading to Hgb measurement error will be addressed in the form of a full 
clinical assessment, and I will also investigate the efficacy of the smartphone image-
based algorithm in which patients will use this app as a self-test using multiple models 
and manufacturers of smartphones. This study will also evaluate and improve upon the 
quality control measures that I have implemented thus far. Overall, this system represents 
the first noninvasive system that can potentially replace blood-based testing without 
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requiring any additional medical equipment. While the current algorithm and app 
development focused specifically on anemia, this approach can potentially be adapted to 
quantitatively diagnose other conditions that manifest in physical exam abnormalities (i.e. 
jaundice and cyanosis)29,30. This technology has the capability to completely shift the 
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